FromID,ToID,Relation_value,Relation_type,Relation_Context_ClinicalPhase,FromType,ToType
3004,25528,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11307,25528,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25529,25528,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7103,25528,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11214,25528,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13139,25530,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25531,25530,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
11307,25532,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7103,25532,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12473,25533,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
6999,25534,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,25534,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13789,25535,retinoid receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25536,25537,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2788,25538,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,25538,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25520,25539,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25540,25541,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25542,25543,nicotinic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25544,25545,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13991,25545,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25546,25545,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11481,25547,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12916,25547,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5770,25547,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6190,25548,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
25549,25550,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25540,25551,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25540,25552,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25553,25554,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25555,25554,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25542,25554,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25549,25556,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
6399,25557,diacylglycerol O acyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4180,25558,stearoyl-CoA desaturase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10608,25559,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
8041,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25561,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25562,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25563,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25564,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25565,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25566,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25519,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25523,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25567,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25568,25560,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25569,25570,GABA receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25571,25570,GABA receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
15774,25570,GABA receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25573,25574,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25575,25576,gonadotropin releasing factor hormone receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
6510,25577,sphingosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13040,25583,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25584,25583,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25585,25583,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25586,25587,platelet activating factor receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25588,25589,calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25590,25589,calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25591,25589,calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
10319,25592,adenosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25520,25593,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
5075,25594,BCL inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
16033,25594,BCL inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13520,25594,BCL inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7762,25595,tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25596,25597,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14201,25598,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7740,25599,PAR agonist,MoA,Preclinical,Gene,Chemical_Compound
9999,25600,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6481,25601,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14201,25601,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5185,25602,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25603,25602,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25604,25602,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7392,25602,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,25602,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25605,25606,urotensin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6809,25609,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,25609,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25626,25630,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25633,25634,polarization inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7333,25659,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25660,25659,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15875,25667,cholesterol inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25668,25667,cholesterol inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2519,25673,gamma glutamyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25680,25681,orexin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25682,25681,orexin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25683,25684,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15295,25684,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9570,25685,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9941,25685,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5184,25685,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15499,25685,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11646,25685,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
2742,25687,aldose reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2742,25689,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6995,25689,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3828,25689,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5655,25689,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25690,25689,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25691,25692,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14201,25693,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
6665,25693,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25522,25694,serotonin receptor agonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25525,25694,serotonin receptor agonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9763,25695,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
5896,25695,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
4603,25695,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
7148,25695,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
13271,25695,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
10260,25695,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
4086,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
12778,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
3041,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
4467,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
10319,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
11199,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
25700,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
8891,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
11307,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
7103,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
2676,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
13924,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
7535,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
12634,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
12212,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
10825,25699,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
5594,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25702,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25703,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14354,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25650,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
2854,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
13204,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10758,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12639,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4086,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12778,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3041,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12119,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3862,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25704,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4467,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25705,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25706,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
15130,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
11481,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
11330,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25707,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3446,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
13259,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25708,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
11401,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6083,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12862,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25709,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10708,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6963,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4181,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25710,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25711,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25712,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25713,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25714,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
13924,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25715,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25716,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14716,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
13773,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4074,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10825,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10978,25701,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25719,25720,solute carrier family member inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14890,25721,adiponectin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13395,25721,adiponectin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25722,25723,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25518,25724,dopamine receptor antagonist|serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25522,25724,dopamine receptor antagonist|serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7333,25726,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25660,25726,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25626,25727,glutamate receptor negative allosteric modulator,MoA,Phase 2,Gene,Chemical_Compound
25626,25728,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
12907,25729,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13590,25729,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11200,25729,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25730,25729,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25731,25729,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25683,25729,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25518,25732,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
11393,25734,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25596,25734,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25735,25734,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8093,25734,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
15425,25734,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25736,25734,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25737,25734,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25738,25734,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
3990,25739,sortilin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,25740,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,25741,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,25742,EGFR inhibitor|JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11600,25742,EGFR inhibitor|JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,25742,EGFR inhibitor|JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,25743,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8748,25744,isocitrate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6693,25745,isocitrate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11461,25746,cell cycle inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25515,25747,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25748,25747,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25749,25747,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25717,25747,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25623,25747,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25652,25747,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6576,25747,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6576,25750,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
9967,25751,retinoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14857,25751,retinoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25672,25751,retinoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
6481,25752,retinoid receptor agonist,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25756,25757,free fatty acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13991,25758,adrenergic receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25759,25760,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25761,25760,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9776,25760,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7320,25760,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2939,25762,core binding factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4074,25763,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25518,25764,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25519,25764,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25520,25764,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14923,25765,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25766,25767,lipoxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4449,25768,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8551,25770,apoptosis stimulant|STAT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25771,25772,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
15452,25773,gonadotropin releasing factor hormone receptor antagonist,MoA,Launched,Gene,Chemical_Compound
4215,25783,aldehyde dehydrogenase activator,MoA,Preclinical,Gene,Chemical_Compound
12989,25784,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9732,25787,phosphatidylglycerophosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,25799,Aurora kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10608,25802,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6190,25802,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10608,25807,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
25680,25809,orexin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25682,25809,orexin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
8386,25811,anticancer agent,MoA,Preclinical,Gene,Chemical_Compound
25567,25813,serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25814,25815,protease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6599,25818,cytochrome P450 inhibitor|HMGCR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11229,25819,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
12320,25819,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
6423,25819,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
25820,25819,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
25756,25819,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
25636,25819,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
12796,25819,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
6190,25819,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
25585,25821,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25585,25822,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,25823,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25824,25823,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25825,25823,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25525,25823,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7079,25823,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,25823,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25826,25823,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25569,25827,benzodiazepine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
2742,25834,aldose reductase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25525,25835,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25555,25836,nicotinic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25837,25836,nicotinic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25683,25838,MET inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10745,25838,MET inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15295,25838,MET inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4229,25841,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15298,25845,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8227,25845,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5659,25845,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6044,25845,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3305,25845,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5178,25845,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13950,25845,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11699,25845,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12907,25845,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25690,25845,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11061,25846,glycine transporter inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25847,25848,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25849,25848,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25766,25850,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25847,25851,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25852,25851,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25853,25851,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25847,25854,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25849,25854,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25853,25854,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25847,25855,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
25849,25855,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
25856,25855,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
6190,25855,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
6481,25857,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25847,25858,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25849,25858,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25623,25859,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25865,25866,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25691,25867,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25865,25867,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25803,25870,xanthine oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15715,25871,PERK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10745,25872,tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9986,25873,MDM inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12097,25874,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,25875,MET inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25876,25877,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6190,25878,TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
25879,25880,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15947,25880,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6608,25880,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4449,25880,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25820,25881,free fatty acid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
5659,25882,CDK inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3305,25882,CDK inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25603,25882,CDK inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6190,25883,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
12097,25884,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,25885,MET inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,25886,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,25886,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25887,25886,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10034,25888,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25889,25890,adrenergic receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7020,25891,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25892,25891,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25892,25905,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25771,25905,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
2742,25912,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25913,25912,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5826,25912,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25913,25914,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10895,25917,dihydrofolate reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9813,25917,dihydrofolate reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15298,25918,CDK inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,25918,CDK inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,25918,CDK inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25698,25921,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13152,25921,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25913,25922,cyclin D inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25892,25928,serotonin transporter (SERT) inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25929,25928,serotonin transporter (SERT) inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25771,25928,serotonin transporter (SERT) inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2676,25950,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25951,25952,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
12989,25954,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8077,25954,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25623,25960,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25961,25962,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25623,25962,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25963,25964,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25961,25964,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
15548,25964,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25965,25964,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25584,25972,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25604,25974,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,25974,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12018,25975,caspase activator,MoA,Phase 2,Gene,Chemical_Compound
25976,25977,cannabinoid receptor agonist|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25847,25977,cannabinoid receptor agonist|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25849,25977,cannabinoid receptor agonist|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6074,25978,tropomyosin receptor kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25979,25980,cholesteryl ester transfer protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25983,25984,growth hormone secretagogue receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25588,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25590,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25591,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25847,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25849,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6354,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25852,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25853,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25986,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8372,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25987,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25988,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6190,25985,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7292,25990,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
25991,25992,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6026,25992,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13922,25992,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3377,25992,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25969,25992,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25993,25994,protein synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25518,25995,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25963,25995,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25961,25995,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15548,25995,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25965,25995,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25525,25995,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25544,25997,lipid peroxidase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25998,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26000,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8606,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3621,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8763,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3556,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14918,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9372,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4103,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9528,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3239,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9058,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9292,25999,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,26001,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
12302,26001,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
25523,26002,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25697,26003,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9097,26004,neuropeptide receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26005,26006,corticotropin releasing factor receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
3033,26008,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11686,26009,ATP synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10608,26010,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
14000,26011,apolipoprotein expression enhancer,MoA,Phase 3,Gene,Chemical_Compound
25586,26012,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4588,26013,RET tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25683,26013,RET tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25604,26013,RET tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4171,26013,RET tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7292,26014,androgen receptor antagonist|anti-inflammatory agent,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25604,26015,KIT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8551,26015,KIT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26016,26017,glucose dependent insulinotropic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
26016,26018,glucose dependent insulinotropic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
14233,26019,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11481,26020,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3613,26020,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12367,26020,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2742,26021,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7292,26021,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3305,26021,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26022,26021,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25911,26021,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3148,26021,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3557,26021,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5253,26024,NADPH oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7382,26025,carboxylesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7230,26025,carboxylesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8546,26026,p53 activator,MoA,Phase 3,Gene,Chemical_Compound
5898,26028,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26029,26028,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26030,26028,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25573,26028,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25623,26034,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
11107,26035,kr√ºppel-like factor expression enhancer,MoA,Phase 1,Gene,Chemical_Compound
6202,26036,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26037,26038,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26039,26038,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9909,26038,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11330,26041,ALK tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12907,26041,ALK tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25564,26042,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8086,26043,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7323,26044,monocarboxylate transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4208,26044,monocarboxylate transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5297,26045,phosphoinositide dependent kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9570,26046,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10885,26047,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26048,26047,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26049,26047,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26050,26047,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8368,26047,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25738,26047,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7829,26047,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7510,26047,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26051,26047,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26053,26054,melanin inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25512,26055,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25514,26055,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25515,26055,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5026,26056,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,26056,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14804,26057,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5659,26057,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5819,26058,thrombin inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25564,26059,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25563,26060,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25564,26060,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25565,26060,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25566,26060,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25563,26061,acetylcholine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25564,26061,acetylcholine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25565,26061,acetylcholine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25566,26061,acetylcholine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
3325,26064,farnesyltransferase inhibitor,MoA,Launched,Gene,Chemical_Compound
13922,26064,farnesyltransferase inhibitor,MoA,Launched,Gene,Chemical_Compound
3004,26066,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3613,26068,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15188,26069,kinesin-like spindle protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,26070,EGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25636,26077,astrocyte modulating agent,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26078,26077,astrocyte modulating agent,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
15528,26079,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26016,26080,glucose dependent insulinotropic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13626,26081,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26082,26083,SHIP2 phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25820,26084,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12199,26085,interleukin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,26086,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,26087,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,26087,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,26088,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15643,26088,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26089,26090,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
26091,26090,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
13006,26090,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
25636,26092,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7292,26093,androgen receptor enhancer,MoA,Phase 2,Gene,Chemical_Compound
14171,26094,calcineurin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25690,26098,apoptosis stimulant,MoA,Preclinical,Gene,Chemical_Compound
25843,26099,opioid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
11061,26100,glycine transporter inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11330,26105,ALK tyrosine kinase receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12907,26106,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,26106,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13040,26107,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
5402,26107,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25926,26107,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25913,26108,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26109,26108,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25525,26110,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15298,26111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8227,26111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5659,26111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6044,26111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3305,26111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11699,26111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13343,26112,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8285,26112,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11600,26112,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5775,26112,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12535,26112,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13288,26112,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9776,26114,cyclooxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11600,26117,JAK inhibitor|STAT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8551,26117,JAK inhibitor|STAT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3004,26118,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11307,26118,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25529,26118,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7103,26118,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8497,26119,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
6567,26119,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
15105,26119,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
13890,26119,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
8327,26126,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5173,26127,endothelin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25563,26129,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25564,26129,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25565,26129,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25566,26129,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9280,26129,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11481,26130,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3613,26130,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12367,26130,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13626,26130,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9902,26130,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3328,26130,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4229,26131,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3613,26132,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26132,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12916,26132,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5770,26132,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,26134,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15178,26136,autotaxin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,26137,protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,26137,protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12473,26138,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
8514,26139,gamma secretase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7230,26141,ACAT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26144,26145,angiotensin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25607,26146,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6491,26146,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13152,26147,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11666,26147,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12018,26152,caspase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25540,26153,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26154,26155,hedgehog pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9018,26156,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5450,26156,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13040,26158,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10635,26159,purine antagonist,MoA,Preclinical,Gene,Chemical_Compound
25636,26161,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
6999,26166,glycogen synthase kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8086,26166,glycogen synthase kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2676,26167,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26168,26167,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3068,26167,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4071,26169,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,26170,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25837,26170,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3105,26171,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11600,26171,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5775,26171,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26172,26173,CRTH receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7640,26174,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8086,26175,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,26176,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11330,26177,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,26177,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7292,26178,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
12907,26179,EGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
6908,26180,beta-secretase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7323,26181,monocarboxylate transporter inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6399,26182,diacylglycerol kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26183,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26185,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4400,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26186,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26187,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
8980,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26188,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
6268,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15618,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26189,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
6354,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
3070,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26190,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7731,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26191,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26192,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14530,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26193,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25852,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26194,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25623,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
11142,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4203,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14160,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14968,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25625,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4647,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9814,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
6708,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26195,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26196,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
8124,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26197,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
11061,26184,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
5212,26198,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25730,26198,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25731,26198,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26199,26198,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
11627,26198,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25683,26198,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26200,26201,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11481,26202,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3613,26202,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12367,26202,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25926,26203,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4198,26204,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26205,26204,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8344,26204,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,26206,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6809,26206,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,26206,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25817,26206,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15816,26207,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25623,26208,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
3724,26209,pyruvate dehydrogenase kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6399,26210,diacylglycerol O acyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7517,26211,CHK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8332,26211,CHK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7640,26212,mTOR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6809,26213,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,26213,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13225,26214,MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,26215,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,26215,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12907,26216,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13590,26216,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26217,26216,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25626,26218,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11393,26219,estrogen receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
26220,26221,elastase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26226,26227,RAGE receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26091,26232,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
15786,26235,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13005,26237,DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15816,26238,ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,26238,ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8682,26239,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,26240,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11600,26241,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11173,26242,polynucleotide kinase/phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26243,26244,ICAM1 expression inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25641,26244,ICAM1 expression inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25544,26245,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9637,26246,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25540,26247,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25516,26248,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6399,26249,diacylglycerol O acyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10141,26253,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10758,26254,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5820,26254,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13780,26254,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25817,26255,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25766,26256,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6843,26256,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7432,26256,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26257,26256,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25642,26256,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25969,26256,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25803,26256,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7902,26259,DNA polymerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10141,26260,insulin sensitizer|PPAR receptor partial agonist,MoA,Phase 3,Gene,Chemical_Compound
5877,26261,cathepsin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9474,26264,BAX activator,MoA,Preclinical,Gene,Chemical_Compound
26265,26266,nociceptin/orphanin FQ receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12989,26267,topoisomerase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13343,26268,Aurora kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
8285,26268,Aurora kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
8285,26269,Aurora kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25913,26270,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 1,Gene,Chemical_Compound
10141,26270,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 1,Gene,Chemical_Compound
10141,26271,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 3,Gene,Chemical_Compound
8551,26271,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 3,Gene,Chemical_Compound
25626,26273,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26274,26275,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12088,26275,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25655,26275,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6064,26275,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3521,26275,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26276,26275,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25585,26277,histamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9474,26278,cytochrome C release inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15539,26279,L-type calcium channel activator,MoA,Preclinical,Gene,Chemical_Compound
3844,26280,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10968,26281,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26282,26283,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
26284,26283,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
8041,26285,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25697,26285,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,26285,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25698,26285,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26286,26287,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26288,26289,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7902,26290,hypoxia inducible factor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14052,26292,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9106,26293,urokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6190,26294,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
3589,26295,complement inhibitor|serine protease inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14233,26296,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14233,26297,sigma receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,26298,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8514,26302,gamma secretase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25567,26308,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26163,26308,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14645,26309,AMPK inhibitor,MoA,Launched,Gene,Chemical_Compound
6599,26314,gluconeogenesis inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25897,26328,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25899,26328,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25900,26328,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25901,26328,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25902,26328,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25903,26328,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
12796,26328,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25717,26337,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26338,26339,CCK receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26340,26339,CCK receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
11834,26347,LDL receptor activator,MoA,Launched,Gene,Chemical_Compound
25991,26348,interleukin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25969,26348,interleukin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7625,26349,beta amyloid synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25569,26350,benzodiazepine receptor ligand,MoA,Launched,Gene,Chemical_Compound
25619,26350,benzodiazepine receptor ligand,MoA,Launched,Gene,Chemical_Compound
3521,26351,apoptosis stimulant,MoA,Launched,Gene,Chemical_Compound
25573,26351,apoptosis stimulant,MoA,Launched,Gene,Chemical_Compound
25722,26352,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25843,26352,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25844,26352,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7640,26353,protein synthesis stimulant,MoA,Launched,Gene,Chemical_Compound
15946,26355,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26364,26365,GLP receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26367,26368,apoptosis stimulant|NFkB pathway inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7640,26371,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9637,26371,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6809,26371,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25817,26371,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26372,26373,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26374,26375,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8439,26375,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15329,26375,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12535,26375,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15528,26376,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14636,26376,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26377,26376,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15336,26376,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9097,26378,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,26379,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,26379,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25887,26379,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14717,26379,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15643,26379,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26380,26381,calcitonin antagonist,MoA,Phase 2,Gene,Chemical_Compound
3725,26381,calcitonin antagonist,MoA,Phase 2,Gene,Chemical_Compound
15447,26381,calcitonin antagonist,MoA,Phase 2,Gene,Chemical_Compound
26382,26383,telomerase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,26384,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,26385,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,26385,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25569,26387,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,26387,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25612,26387,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25571,26387,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25613,26387,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25614,26387,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26388,26387,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4229,26391,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6354,26393,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
3070,26393,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7731,26393,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25567,26393,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
26163,26393,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25826,26395,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26396,26397,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
4266,26398,NFkB pathway inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26399,26398,NFkB pathway inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26400,26398,NFkB pathway inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12477,26402,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
15105,26402,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
12477,26403,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15105,26403,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12616,26404,vitamin B,MoA,Launched,Gene,Chemical_Compound
9763,26404,vitamin B,MoA,Launched,Gene,Chemical_Compound
11977,26404,vitamin B,MoA,Launched,Gene,Chemical_Compound
11211,26404,vitamin B,MoA,Launched,Gene,Chemical_Compound
11374,26404,vitamin B,MoA,Launched,Gene,Chemical_Compound
3845,26404,vitamin B,MoA,Launched,Gene,Chemical_Compound
12963,26404,vitamin B,MoA,Launched,Gene,Chemical_Compound
13047,26404,vitamin B,MoA,Launched,Gene,Chemical_Compound
5413,26404,vitamin B,MoA,Launched,Gene,Chemical_Compound
7863,26405,dipeptidyl peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4198,26407,XIAP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8344,26407,XIAP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26243,26408,lymphocyte function-associated antigen negative modulator,MoA,Preclinical,Gene,Chemical_Compound
4909,26409,tyrosine phosphatase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11481,26410,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26410,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,26410,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,26410,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25879,26410,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,26410,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,26410,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,26410,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,26410,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,26410,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,26410,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10315,26410,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7292,26415,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
11393,26415,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
25596,26415,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
25735,26415,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
10141,26415,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
11393,26416,autotaxin inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25596,26416,autotaxin inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13264,26416,autotaxin inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
26197,26417,glycine transporter inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11061,26417,glycine transporter inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2788,26419,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,26419,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12748,26420,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12748,26421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15491,26421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7003,26422,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26423,26422,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26199,26425,FGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25849,26426,cannabinoid receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
26427,26428,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5173,26429,endothelin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14707,26430,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
15298,26431,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,26431,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4155,26432,fatty acid binding protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5026,26433,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,26433,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,26434,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5178,26434,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11699,26434,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10651,26435,melanocortin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11481,26436,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26437,26436,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,26436,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25779,26436,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,26436,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,26436,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,26436,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,26436,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,26436,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10745,26436,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7392,26436,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,26436,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13152,26438,inosine monophosphate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11666,26438,inosine monophosphate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26439,26440,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
26441,26440,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
12907,26442,EGFR inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,26442,EGFR inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11200,26442,EGFR inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9967,26443,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26243,26444,ICAM1 antagonist|leukocyte function-associated antigen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12907,26445,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13590,26445,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25603,26445,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25683,26445,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11481,26446,IGF-1 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11627,26446,IGF-1 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4293,26447,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26448,26447,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10745,26447,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26449,26447,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9785,26447,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25683,26450,c-Met inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10745,26450,c-Met inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10922,26451,smoothened receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7038,26452,CDC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
2676,26452,CDC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6078,26453,lysophosphatidic acid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25522,26454,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9852,26455,IP1 prostacyclin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25544,26456,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13991,26456,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25546,26456,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,26456,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25722,26457,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25843,26457,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25844,26457,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,26467,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25544,26468,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25546,26468,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25512,26468,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25517,26468,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25518,26468,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25519,26468,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25520,26468,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25522,26468,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7079,26468,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
5173,26469,endothelin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6150,26470,endothelin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
12161,26471,Ras GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12295,26471,Ras GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,26472,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26374,26473,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8439,26473,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15329,26473,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15188,26474,kinesin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8688,26475,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14870,26475,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2942,26481,dihydroorotate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25569,26482,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25611,26482,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25612,26482,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25571,26482,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25613,26482,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25614,26482,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
14804,26485,cyclin D inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25779,26490,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5212,26490,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26149,26490,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25926,26490,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25683,26490,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25731,26491,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25522,26492,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25523,26492,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25524,26492,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25824,26492,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25825,26492,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,26492,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,26492,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,26492,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25933,26492,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7449,26493,cholesterol inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25631,26494,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25775,26494,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25889,26494,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25512,26495,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25514,26495,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25515,26495,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4153,26496,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8147,26496,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25843,26497,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25824,26498,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25825,26498,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7829,26500,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25636,26500,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25775,26505,adrenergic receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25563,26506,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25564,26506,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25565,26506,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25566,26506,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9280,26506,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5178,26507,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26508,26509,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13691,26510,mitotic kinesin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25892,26511,dopamine reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25929,26511,dopamine reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25771,26511,dopamine reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13139,26512,GABA receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15694,26513,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15105,26513,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7020,26514,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
7633,26514,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
26304,26519,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
15499,26519,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
9637,26525,PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25817,26525,PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25631,26527,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
13953,26532,tripeptidyl peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25517,26533,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25518,26533,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25519,26533,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25520,26533,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25521,26533,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25522,26533,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25525,26533,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7591,26535,EGFR inhibitor|SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7658,26537,glutathione transferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25647,26538,carbonic anhydrase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3557,26540,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4909,26541,tyrosine phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6921,26541,tyrosine phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5751,26541,tyrosine phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25766,26542,lipoxygenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25766,26543,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25722,26544,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25844,26544,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25722,26545,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7020,26546,monoamine oxidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25525,26547,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7079,26547,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,26547,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8227,26548,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,26548,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26548,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,26548,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3724,26548,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5297,26548,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,26549,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,26549,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26549,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,26549,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3724,26549,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5297,26549,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,26550,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26551,26552,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7247,26553,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26565,26566,calcium-activated chloride channel inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25766,26567,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10043,26567,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3844,26568,HIV integrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26582,26583,calcium sensing receptor negative allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26233,26584,motilin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
11481,26585,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14776,26585,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12895,26585,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6322,26585,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6190,26588,TRPV activator,MoA,Phase 1,Gene,Chemical_Compound
15946,26589,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11481,26593,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12907,26593,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13590,26593,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11200,26593,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12016,26594,mineralocorticoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
8041,26595,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6190,26598,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
6139,26598,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
7850,26600,ribonucleotide reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26633,26634,calcium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
5948,26635,angiotensin antagonist,MoA,Phase 1,Gene,Chemical_Compound
3188,26636,WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13040,26637,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15168,26640,NADPH quinone oxidoreductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11988,26641,sodium/hydrogen exchanger inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25775,26644,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25518,26645,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7020,26647,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7633,26647,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
2512,26654,GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3928,26655,glucosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4689,26655,glucosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2744,26656,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4497,26656,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26657,26656,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,26658,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7292,26659,androgen receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
11104,26660,valosin-containing protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10125,26661,glutaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26396,26662,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25766,26663,lipoxygenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7640,26664,DNA protein kinase inhibitor|mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7640,26665,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9097,26666,JNK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7661,26667,apoptosis stimulant,MoA,Preclinical,Gene,Chemical_Compound
12487,26667,apoptosis stimulant,MoA,Preclinical,Gene,Chemical_Compound
12463,26668,G protein signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26669,26668,G protein signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12463,26670,G protein signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12463,26671,G protein signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25542,26672,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
3188,26673,WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4229,26674,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4111,26674,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,26675,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,26675,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25887,26675,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,26676,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,26676,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25887,26676,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25837,26677,nicotinic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6665,26678,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6665,26679,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15298,26680,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,26680,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26680,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11699,26681,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25626,26682,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26265,26683,opioid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25844,26683,opioid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
5185,26684,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26149,26684,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25603,26684,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26150,26684,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25683,26684,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25604,26684,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7392,26684,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,26684,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9018,26694,RAF inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5450,26694,RAF inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11600,26695,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11330,26696,ALK tyrosine kinase receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26338,26700,CCK receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8337,26701,ACAT inhibitor|cholesterol inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26702,26703,triacylglycerol lipase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7762,26708,microtubule stimulant|tubulin polymerization inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26709,26710,rap guanine nucleotide exchange factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26022,26711,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
8041,26712,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25697,26712,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
9810,26712,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25698,26712,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8041,26713,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,26713,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25698,26713,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12946,26714,ATM kinase inhibitor|ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15816,26714,ATM kinase inhibitor|ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9986,26715,MDM inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25631,26716,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25775,26716,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25889,26716,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
13139,26717,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25631,26718,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25889,26718,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12796,26719,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11142,26720,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4203,26720,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14160,26720,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14968,26720,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
12907,26721,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,26722,EGFR inhibitor|PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26723,26722,EGFR inhibitor|PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13139,26724,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25531,26724,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10388,26724,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2657,26724,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26252,26724,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13139,26725,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25531,26725,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10388,26725,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2657,26725,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26252,26725,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8285,26726,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,26726,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3103,26726,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4881,26726,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,26726,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,26727,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,26727,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26728,26729,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15298,26730,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13139,26731,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
8041,26732,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25697,26732,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,26732,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25698,26732,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25569,26733,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25611,26733,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25612,26733,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25571,26733,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25613,26733,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25614,26733,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
8041,26734,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25697,26734,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,26734,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25698,26734,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25569,26735,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25616,26735,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25619,26735,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5212,26736,fibroblast growth factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25730,26736,fibroblast growth factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25731,26736,fibroblast growth factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7323,26737,monocarboxylate transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8514,26740,gamma secretase modulator,MoA,Phase 2,Gene,Chemical_Compound
10043,26741,glutamate inhibitor|macrophage migration inhibiting factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,26743,CHK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6999,26744,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26744,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,26745,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6999,26745,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26745,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,26745,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25717,26747,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25569,26749,GABA receptor modulator,MoA,Withdrawn,Gene,Chemical_Compound
6859,26766,acetylcholinesterase inhibitor,MoA,Launched,Gene,Chemical_Compound
6859,26776,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
7382,26776,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
25662,26776,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
2628,26776,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
26777,26776,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
26778,26776,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
8093,26776,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
3540,26776,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
25626,26779,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26780,26781,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2742,26782,breast cancer resistance protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3305,26782,breast cancer resistance protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25911,26782,breast cancer resistance protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3148,26782,breast cancer resistance protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12907,26783,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,26783,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6024,26784,aryl hydrocarbon receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7640,26785,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,26785,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6809,26785,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,26785,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25817,26785,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6481,26786,retinoid receptor binder,MoA,Preclinical,Gene,Chemical_Compound
14201,26786,retinoid receptor binder,MoA,Preclinical,Gene,Chemical_Compound
26787,26788,GAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7512,26789,ACAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7230,26789,ACAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7829,26790,fatty acid synthase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7829,26793,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25636,26793,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25853,26794,G protein-coupled receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6958,26795,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26522,26796,G protein-coupled receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5719,26797,MAP kinase phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10141,26798,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26799,26800,dehydropeptidase inhibitor,MoA,Launched,Gene,Chemical_Compound
6567,26802,integrin antagonist,MoA,Phase 3,Gene,Chemical_Compound
13890,26802,integrin antagonist,MoA,Phase 3,Gene,Chemical_Compound
3004,26804,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11307,26804,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7103,26804,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12418,26805,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12939,26805,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9069,26807,transient receptor potential channel agonist,MoA,Preclinical,Gene,Chemical_Compound
25631,26808,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25775,26808,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25889,26808,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26282,26814,guanylate cyclase activator,MoA,Phase 2,Gene,Chemical_Compound
26284,26814,guanylate cyclase activator,MoA,Phase 2,Gene,Chemical_Compound
26815,26816,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25525,26817,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26819,26820,P glycoprotein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10608,26821,aldose reductase inhibitor|TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
26739,26822,CAR antagonist,MoA,Preclinical,Gene,Chemical_Compound
26823,26822,CAR antagonist,MoA,Preclinical,Gene,Chemical_Compound
10141,26822,CAR antagonist,MoA,Preclinical,Gene,Chemical_Compound
5898,26824,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26029,26824,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26030,26824,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3521,26824,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11446,26824,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26276,26824,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25573,26824,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25512,26827,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25515,26827,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25585,26827,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25932,26827,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25567,26827,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,26828,glutamate receptor potentiator,MoA,Preclinical,Gene,Chemical_Compound
14968,26828,glutamate receptor potentiator,MoA,Preclinical,Gene,Chemical_Compound
25544,26829,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26396,26831,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26832,26831,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26833,26831,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25951,26831,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26834,26831,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26109,26835,nitric oxide stimulant,MoA,Phase 1,Gene,Chemical_Compound
25525,26836,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25525,26837,serotonin receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25567,26837,serotonin receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25826,26837,serotonin receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25926,26837,serotonin receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26823,26841,constitutive androstane receptor (CAR) agonist,MoA,Preclinical,Gene,Chemical_Compound
2742,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14671,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4603,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26845,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26846,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25648,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26847,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4546,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13223,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26193,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11012,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12759,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26848,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3032,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14897,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8994,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10043,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11214,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25899,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6099,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26849,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26850,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11622,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5392,26844,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25826,26851,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13758,26852,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10115,26852,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9000,26852,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8752,26852,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15017,26852,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8759,26852,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5396,26852,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11600,26853,NFkB pathway inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7355,26853,NFkB pathway inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14325,26854,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25569,26855,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25611,26855,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25612,26855,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25613,26855,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25616,26855,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25619,26855,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25843,26865,chelating agent,MoA,Withdrawn,Gene,Chemical_Compound
13040,26866,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25584,26866,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25585,26866,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25932,26866,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26091,26876,potassium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
5402,26876,potassium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
7020,26886,monoamine oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26050,26891,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25889,26893,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26894,26893,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14357,26893,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26895,26893,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25575,26896,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,26896,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25963,26897,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25961,26897,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15548,26897,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25965,26897,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
12907,26898,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25607,26899,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4203,26900,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25795,26901,sodium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
25797,26901,sodium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
15921,26934,adenylyl cyclase activator,MoA,Phase 2,Gene,Chemical_Compound
12009,26934,adenylyl cyclase activator,MoA,Phase 2,Gene,Chemical_Compound
6908,26935,beta-secretase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,26936,DNA dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,26936,DNA dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25849,26940,cannabinoid receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
7333,26941,PKC inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4909,26941,PKC inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7333,26942,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15076,26942,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12016,26942,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7292,26945,androgen receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13234,26946,MAPK-interacting kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13234,26947,MAPK-interacting kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12212,26950,glycogen phosphorylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26089,26951,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26005,26952,corticotropin releasing factor receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26029,26953,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26030,26953,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3521,26953,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11446,26953,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25573,26953,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25979,26954,cholesteryl ester transfer protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12616,26955,acetyl-CoA carboxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9763,26955,acetyl-CoA carboxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25604,26956,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7392,26956,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,26956,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,26957,EGFR inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8337,26958,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12212,26959,glycogen phosphorylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25522,26960,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25523,26961,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25847,26962,cannabinoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12473,26963,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
26964,26965,carboxypeptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26966,26965,carboxypeptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26967,26968,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15528,26969,bromodomain inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25969,26970,tumor necrosis factor release inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11100,26971,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15528,26972,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11100,26973,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13824,26974,pyruvate dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25623,26975,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11142,26975,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
4203,26975,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14160,26975,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14968,26975,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10043,26976,macrophage migration inhibiting factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5185,26981,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25603,26981,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25604,26981,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7392,26981,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,26981,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12683,26985,MTH1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8551,26989,acetylcholinesterase inhibitor|STAT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9645,26990,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25929,26991,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25700,26992,fructose biphosphate inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12477,26993,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25626,26994,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26029,26995,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26030,26995,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3521,26995,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11446,26995,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25573,26995,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6908,26996,beta-secretase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8859,26997,toll-like receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26998,26999,toll-like receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27000,26999,toll-like receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12907,27001,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,27001,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8344,27002,apoptosis inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9941,27003,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5177,27003,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26154,27004,smoothened receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
27005,27004,smoothened receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
10922,27004,smoothened receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7625,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
10748,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
7555,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25646,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25647,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25648,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
26652,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
26653,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25565,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25779,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
11040,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
9531,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
26030,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25573,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25913,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
7829,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25636,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25803,27006,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
3105,27007,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11600,27007,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5775,27007,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14233,27008,sigma receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25697,27009,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4215,27010,aldehyde dehydrogenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5770,27011,PKA activator,MoA,Preclinical,Gene,Chemical_Compound
11536,27012,casein kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6700,27012,casein kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
3594,27012,casein kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
2826,27012,casein kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25631,27016,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25522,27016,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25524,27016,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9528,27022,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26372,27027,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,27036,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,27036,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25683,27036,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27037,27038,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27037,27039,sphingosine 1-phosphate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27040,27041,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27042,27043,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6723,27044,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12316,27045,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7762,27051,tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8974,27056,microtubule inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3105,27057,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11600,27057,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5775,27057,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25516,27058,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4204,27059,leucine rich repeat kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,27060,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14448,27065,toll-like receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9531,27066,histone acetyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27068,27069,enkephalinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27070,27069,enkephalinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25668,27069,enkephalinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6354,27071,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25623,27071,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11142,27071,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
4203,27071,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14160,27071,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14968,27071,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
27072,27071,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8901,27073,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10658,27073,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7264,27073,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7762,27074,microtubule inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9535,27075,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9570,27081,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9941,27081,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5184,27081,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11348,27081,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11002,27081,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15499,27081,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26306,27081,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11646,27081,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3799,27081,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12907,27082,EGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
13590,27082,EGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
11200,27082,EGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
2833,27084,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
27085,27084,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25735,27084,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26763,27084,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4215,27086,antioxidant,MoA,Phase 1,Gene,Chemical_Compound
25844,27087,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25979,27089,cholesteryl ester transfer protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26884,27113,thromboxane receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12416,27114,KDM2A inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15241,27114,KDM2A inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11184,27114,KDM2A inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26200,27117,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13343,27119,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8285,27119,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25887,27119,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5212,27119,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25937,27119,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4171,27119,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7841,27119,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25779,27122,non-nucleoside reverse transcriptase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3308,27122,non-nucleoside reverse transcriptase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15280,27124,hypoxia inducible factor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27126,27127,phospholipase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10141,27128,PPAR receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
5173,27132,endothelin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25565,27138,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15890,27140,thromboxane synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15890,27141,thromboxane synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12018,27142,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7351,27143,dipeptidyl peptidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25820,27144,free fatty acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25604,27145,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7392,27145,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27146,27147,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27148,27147,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
13006,27147,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
26843,27149,chloride channel blocker|gap junction modulator|glutamate inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5998,27150,discoidin domain receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12793,27150,discoidin domain receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,27153,JAK inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
9052,27155,focal adhesion kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7640,27160,mTOR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6859,27162,acetylcholinesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26458,27166,proteasome inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25814,27166,proteasome inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25779,27166,proteasome inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26220,27166,proteasome inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6843,27170,membrane permeability inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6599,27171,HMGCR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5261,27172,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12016,27175,progestogen hormone,MoA,Preclinical,Gene,Chemical_Compound
25544,27176,adrenergic receptor agonist|dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25517,27176,adrenergic receptor agonist|dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25518,27176,adrenergic receptor agonist|dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13040,27177,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,27188,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14109,27194,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12016,27194,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6859,27195,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26022,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27201,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26833,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25951,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26834,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10849,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5297,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2676,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5770,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25737,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12212,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25690,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27202,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27203,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27072,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13891,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14320,27200,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26338,27206,CCK receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25698,27208,calmodulin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25626,27214,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12385,27215,PPAR receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25755,27216,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25712,27218,adenosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25713,27218,adenosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25596,27219,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25517,27225,dopamine reuptake inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7020,27225,dopamine reuptake inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7633,27225,dopamine reuptake inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11393,27233,estrogen receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25596,27233,estrogen receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
27085,27233,estrogen receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25735,27233,estrogen receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
10693,27237,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7829,27240,prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25636,27240,prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25517,27241,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25518,27241,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25519,27241,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25520,27241,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25521,27241,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26967,27245,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25626,27245,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25584,27249,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25585,27249,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25932,27249,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13040,27253,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25895,27256,angiotensin converting enzyme activator,MoA,Phase 3,Gene,Chemical_Compound
9157,27256,angiotensin converting enzyme activator,MoA,Phase 3,Gene,Chemical_Compound
26586,27256,angiotensin converting enzyme activator,MoA,Phase 3,Gene,Chemical_Compound
15298,27258,CDK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8227,27258,CDK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6044,27258,CDK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11699,27258,CDK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25829,27260,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
3489,27260,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25831,27260,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25832,27260,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25759,27260,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26172,27260,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25761,27260,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
9776,27260,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
7320,27260,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25833,27260,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
6297,27260,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26884,27260,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25876,27261,apoptosis stimulant,MoA,Preclinical,Gene,Chemical_Compound
25913,27267,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26109,27267,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25626,27269,glutamate receptor negative allosteric modulator,MoA,Phase 2,Gene,Chemical_Compound
25522,27270,dopamine reuptake inhibitor|serotonin reuptake inhibitor,MoA,Launched,Gene,Chemical_Compound
25525,27270,dopamine reuptake inhibitor|serotonin reuptake inhibitor,MoA,Launched,Gene,Chemical_Compound
25526,27270,dopamine reuptake inhibitor|serotonin reuptake inhibitor,MoA,Launched,Gene,Chemical_Compound
10748,27279,immunostimulant,MoA,Phase 3,Gene,Chemical_Compound
25647,27279,immunostimulant,MoA,Phase 3,Gene,Chemical_Compound
25648,27279,immunostimulant,MoA,Phase 3,Gene,Chemical_Compound
25623,27280,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11142,27280,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4203,27280,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14233,27280,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25623,27281,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,27281,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,27281,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,27281,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14968,27281,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25542,27282,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25626,27283,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
12119,27284,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,27285,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26689,27286,elastase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25963,27287,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25961,27287,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8327,27287,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25623,27287,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,27287,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,27287,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25766,27289,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25820,27291,PPAR receptor agonist,MoA,Launched,Gene,Chemical_Compound
7829,27291,PPAR receptor agonist,MoA,Launched,Gene,Chemical_Compound
25636,27291,PPAR receptor agonist,MoA,Launched,Gene,Chemical_Compound
25702,27295,MRP inhibitor|P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5402,27296,potassium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25926,27296,potassium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
9812,27296,potassium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
8368,27296,potassium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
7762,27298,tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25522,27302,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25523,27302,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25524,27302,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25824,27302,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25825,27302,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25525,27302,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25527,27302,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25933,27302,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25879,27304,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15947,27304,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6608,27304,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,27304,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12119,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2805,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7729,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27135,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14171,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26149,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25603,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3103,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13924,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26374,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,27306,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5185,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12907,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5212,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25730,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25731,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26149,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25603,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26150,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6218,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25683,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25604,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7392,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,27309,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8041,27318,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25697,27318,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9810,27318,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25698,27318,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25775,27319,sodium channel activator,MoA,Phase 2,Gene,Chemical_Compound
26091,27320,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25702,27321,histamine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13040,27321,histamine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14160,27322,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14968,27322,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13754,27323,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5938,27323,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25934,27324,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8901,27325,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11393,27326,selective estrogen receptor modulator (SERM),MoA,Phase 3,Gene,Chemical_Compound
15499,27334,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11646,27334,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27292,27335,toll-like receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27336,27337,structural glycoprotein antagonist,MoA,Phase 1,Gene,Chemical_Compound
13890,27337,structural glycoprotein antagonist,MoA,Phase 1,Gene,Chemical_Compound
25636,27339,cyclooxygenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,27341,PI3K inhibitor,MoA,Launched,Gene,Chemical_Compound
6809,27341,PI3K inhibitor,MoA,Launched,Gene,Chemical_Compound
12097,27341,PI3K inhibitor,MoA,Launched,Gene,Chemical_Compound
25817,27341,PI3K inhibitor,MoA,Launched,Gene,Chemical_Compound
10933,27344,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9751,27344,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9441,27344,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10933,27345,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27085,27347,estrogen-related receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25735,27347,estrogen-related receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4684,27348,gamma secretase modulator,MoA,Phase 1,Gene,Chemical_Compound
9297,27348,gamma secretase modulator,MoA,Phase 1,Gene,Chemical_Compound
12083,27348,gamma secretase modulator,MoA,Phase 1,Gene,Chemical_Compound
5402,27349,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
25926,27349,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
5876,27350,calpain inhibitor|cysteine protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27351,27352,calcium-activated chloride channel inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,27353,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2742,27355,aldose reductase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25584,27356,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
27357,27358,cyclooxygenase inhibitor|glutathione peroxidase agonist|H+/K+-ATPase inhibitor|nitric oxide synthase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4229,27359,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4111,27359,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6481,27360,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14201,27360,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6665,27360,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10141,27366,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6427,27370,polycomb protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27371,27372,hemoglobin oxygen release stimulant,MoA,Phase 3,Gene,Chemical_Compound
27274,27372,hemoglobin oxygen release stimulant,MoA,Phase 3,Gene,Chemical_Compound
25697,27373,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10141,27374,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12907,27378,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26396,27379,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26832,27379,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26833,27379,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26834,27379,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12186,27380,neuropilin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8975,27381,Ras GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27382,27381,Ras GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25512,27383,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25897,27383,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25899,27383,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25913,27384,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26109,27384,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11100,27385,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25702,27386,P glycoprotein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6777,27387,exportin antagonist,MoA,Phase 1,Gene,Chemical_Compound
14769,27388,antineoplastic agent,MoA,Phase 3,Gene,Chemical_Compound
8337,27389,PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
12385,27389,PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
10141,27389,PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25575,27390,gonadotropin releasing factor hormone receptor antagonist,MoA,Launched,Gene,Chemical_Compound
6126,27391,bone formation stimulant,MoA,Phase 3,Gene,Chemical_Compound
13141,27392,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
4071,27395,purinergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25623,27396,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4203,27396,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
10748,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7555,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25646,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25647,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10749,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25648,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26489,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13433,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26652,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25649,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26653,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11536,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8086,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5770,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7247,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26723,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12173,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26288,27397,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6455,27398,bradykinin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25569,27399,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25611,27399,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25612,27399,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25571,27399,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25613,27399,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25614,27399,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25616,27399,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25619,27399,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25522,27400,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25523,27400,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8344,27403,HCV inhibitor|XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10745,27404,hepatocyte growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25933,27405,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27406,27407,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5948,27408,angiotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9319,27410,protein synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11536,27411,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4815,27413,caspase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12018,27413,caspase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12936,27413,caspase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25569,27417,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
7800,27419,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,27419,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11393,27420,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
2583,27424,dihydropyrimidine dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11857,27424,dihydropyrimidine dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25803,27424,dihydropyrimidine dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13343,27425,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25603,27425,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25683,27425,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7392,27425,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9052,27425,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15786,27425,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8041,27430,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25697,27430,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9810,27430,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25698,27430,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3004,27430,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11307,27430,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9570,27432,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9941,27432,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5184,27432,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3799,27432,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11481,27436,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8086,27436,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7247,27436,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26723,27436,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15425,27436,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27437,27436,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15397,27438,endoplasmic reticulum oxidation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25879,27439,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,27439,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27440,27441,"indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
13973,27447,steroid,MoA,Preclinical,Gene,Chemical_Compound
6908,27448,bacterial DNA gyrase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4277,27448,bacterial DNA gyrase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26220,27449,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
9531,27449,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4277,27449,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4710,27449,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
3464,27449,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
3521,27449,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
7762,27459,microtubule stabilizing agent|tubulin polymerization inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7762,27460,microtubule stabilizing agent|tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27461,27462,trace amine associated receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11705,27464,amyloid protein inhibitor|antiamyloidogenic agent,MoA,Phase 3,Gene,Chemical_Compound
4882,27467,histone lysine methyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4882,27468,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11100,27469,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11100,27470,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6929,27471,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10552,27472,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3557,27473,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11393,27474,estrogen receptor agonist,MoA,Launched,Gene,Chemical_Compound
25596,27474,estrogen receptor agonist,MoA,Launched,Gene,Chemical_Compound
26288,27475,mediator release inhibitor|SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6481,27476,retinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5610,27477,ion channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
12907,27478,EGFR inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6126,27479,vitamin D receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
5212,27480,FGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
25730,27480,FGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
25731,27480,FGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
26199,27480,FGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
15491,27484,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11393,27486,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25596,27486,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25722,27492,acetylcholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25844,27492,acetylcholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26709,27493,EPAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14283,27493,EPAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11393,27497,selective estrogen receptor modulator (SERM),MoA,Phase 3,Gene,Chemical_Compound
11393,27500,contraceptive agent,MoA,Preclinical,Gene,Chemical_Compound
15774,27509,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3004,27509,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4919,27510,beta catenin inhibitor|porcupine inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25518,27519,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25519,27519,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25520,27519,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25519,27523,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
8215,27531,carnitine palmitoyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,27536,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,27536,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,27536,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,27536,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6481,27538,protein synthesis inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25672,27538,protein synthesis inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7625,27541,catalase stimulant,MoA,Preclinical,Gene,Chemical_Compound
16048,27541,catalase stimulant,MoA,Preclinical,Gene,Chemical_Compound
25979,27542,cholesteryl ester transfer protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25963,27543,glutamate receptor negative allosteric modulator,MoA,Launched,Gene,Chemical_Compound
4909,27543,glutamate receptor negative allosteric modulator,MoA,Launched,Gene,Chemical_Compound
9776,27544,prostaglandin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25833,27544,prostaglandin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6190,27546,ATPase inhibitor|TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
25542,27547,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
3862,27548,TGF beta receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2774,27548,TGF beta receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10315,27549,SIRT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27550,27551,growth hormone releasing factor agonist,MoA,Phase 2,Gene,Chemical_Compound
25983,27551,growth hormone releasing factor agonist,MoA,Phase 2,Gene,Chemical_Compound
15946,27552,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5074,27555,cadherin antagonist,MoA,Phase 2,Gene,Chemical_Compound
26053,27556,nootropic agent,MoA,Withdrawn,Gene,Chemical_Compound
11214,27557,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7800,27558,WNT signaling inhibitor negative control,MoA,Preclinical,Gene,Chemical_Compound
14627,27559,glutathione transferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3287,27562,utrophin enhancer,MoA,Phase 2,Gene,Chemical_Compound
13754,27563,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9999,27563,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7800,27563,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11431,27563,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25522,27564,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
5932,27566,glucosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25525,27569,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7848,27570,Ras GTPase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7829,27576,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
25636,27576,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
27333,27580,tryptophan hydroxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27581,27580,tryptophan hydroxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27582,27580,tryptophan hydroxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7079,27583,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25626,27585,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25775,27593,adrenergic receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
6481,27595,apoptosis stimulant|retinoid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
13590,27597,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10748,27598,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
7555,27598,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
25646,27598,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
25647,27598,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
25648,27598,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
26652,27598,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
26653,27598,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
26739,27600,FXR agonist,MoA,Preclinical,Gene,Chemical_Compound
15280,27602,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13964,27602,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7902,27602,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15280,27603,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13964,27603,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7545,27603,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9535,27604,inositol monophosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9535,27605,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12385,27606,PPAR receptor antagonist|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10141,27606,PPAR receptor antagonist|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2742,27607,aldose reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15188,27608,kinesin inhibitor|kinesin-like spindle protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3105,27609,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11600,27609,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5775,27609,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10662,27609,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8093,27614,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3540,27614,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12477,27615,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
3305,27617,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4277,27617,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25722,27618,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25844,27619,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25636,27620,cyclooxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13063,27621,niacinamide phosphoribosyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12473,27622,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25568,27622,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
14707,27629,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
13006,27629,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
25936,27629,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
26345,27629,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
5524,27629,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
2789,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
27351,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
7292,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
8143,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26607,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26608,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26609,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26610,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26611,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9579,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26612,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26613,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26614,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26615,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26616,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26617,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26618,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
5740,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26619,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26620,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26621,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26622,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26623,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26624,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10624,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26625,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26626,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25899,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
7829,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25636,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26763,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26051,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
27641,27640,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10758,27642,Bcr-Abl kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,27642,Bcr-Abl kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25522,27658,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25523,27658,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
9297,27660,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6908,27660,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7027,27660,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8514,27660,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15929,27660,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7829,27660,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25636,27660,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26149,27672,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26150,27672,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25683,27672,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,27672,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26771,27674,alcohol dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26591,27674,alcohol dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25586,27677,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
15921,27678,adenylyl cyclase activator,MoA,Launched,Gene,Chemical_Compound
12009,27678,adenylyl cyclase activator,MoA,Launched,Gene,Chemical_Compound
4308,27678,adenylyl cyclase activator,MoA,Launched,Gene,Chemical_Compound
27680,27681,tubulin polymerization inhibitor|VE-cadherin antagonist,MoA,Phase 3,Gene,Chemical_Compound
5460,27688,WNT5a peptide mimetic,MoA,Phase 2,Gene,Chemical_Compound
15539,27689,calcium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25944,27689,calcium channel activator,MoA,Preclinical,Gene,Chemical_Compound
26226,27690,RAGE receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5173,27691,endothelin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15365,27692,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5719,27692,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7178,27693,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7386,27693,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8342,27693,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3944,27693,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27062,27694,elastase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26220,27694,elastase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10034,27702,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15890,27703,thromboxane synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7264,27705,TGF beta receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6859,27706,acetylcholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5193,27707,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5193,27708,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25569,27722,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25611,27722,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25612,27722,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25571,27722,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25613,27722,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25614,27722,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25619,27722,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25569,27725,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25611,27725,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25612,27725,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25571,27725,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25613,27725,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25614,27725,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25617,27725,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
27726,27725,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
27727,27725,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
27728,27725,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7292,27737,androgen receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25581,27737,androgen receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
10748,27739,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7555,27739,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25646,27739,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25647,27739,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25648,27739,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26652,27739,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26653,27739,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25642,27739,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5075,27741,caspase activator,MoA,Phase 2,Gene,Chemical_Compound
13139,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25531,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25569,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25611,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25612,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25613,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25616,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25619,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26188,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10388,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
2657,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26252,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26787,27742,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7829,27743,cyclooxygenase inhibitor|prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25636,27743,cyclooxygenase inhibitor|prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25569,27744,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25611,27744,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25612,27744,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25571,27744,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25613,27744,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25614,27744,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
4229,27745,HSP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27746,27747,GLI antagonist,MoA,Preclinical,Gene,Chemical_Compound
27746,27748,GLI antagonist,MoA,Preclinical,Gene,Chemical_Compound
14195,27748,GLI antagonist,MoA,Preclinical,Gene,Chemical_Compound
7731,27750,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25623,27750,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
11142,27750,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4203,27750,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14160,27750,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14968,27750,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25624,27750,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25625,27750,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
5948,27751,dopamine reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25929,27751,dopamine reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25929,27752,dopamine reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,27753,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3613,27753,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12367,27753,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8196,27753,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4198,27754,XIAP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26205,27754,XIAP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27755,27754,XIAP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8344,27754,XIAP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,27756,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11393,27757,selective estrogen receptor destabilizer,MoA,Phase 2,Gene,Chemical_Compound
25607,27758,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9018,27759,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,27760,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6809,27760,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12097,27760,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25817,27760,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27136,27761,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27762,27761,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7640,27761,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,27761,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6809,27761,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12097,27761,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25817,27761,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26288,27761,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15365,27763,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5719,27763,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4229,27764,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4229,27766,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13437,27768,apoptosis inhibitor|DNA synthesis inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7850,27768,apoptosis inhibitor|DNA synthesis inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14652,27768,apoptosis inhibitor|DNA synthesis inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26364,27771,GLP receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26022,27772,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
11393,27772,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25596,27772,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
2833,27772,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
27085,27772,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25735,27772,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
15076,27772,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
13677,27772,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
10141,27772,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
14351,27772,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
12989,27772,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26763,27772,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4203,27774,glutamate receptor downregulator,MoA,Phase 3,Gene,Chemical_Compound
7471,27775,glucosylceramidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15946,27776,topoisomerase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5297,27778,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2676,27778,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15374,27778,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25738,27778,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27779,27780,gamma glutamyltransferase Inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4992,27781,GGTase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25603,27782,FLT3 inhibitor,MoA,Launched,Gene,Chemical_Compound
6354,27784,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7731,27784,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6354,27785,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
3070,27785,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26190,27785,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
7731,27785,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25567,27785,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26163,27785,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25636,27786,NFkB pathway inhibitor|nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25926,27787,angiogenesis inhibitor|apoptosis stimulant,MoA,Launched,Gene,Chemical_Compound
9570,27788,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9941,27788,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5184,27788,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11348,27788,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11002,27788,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15499,27788,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26306,27788,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11646,27788,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3799,27788,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27789,27790,glucokinase activator,MoA,Preclinical,Gene,Chemical_Compound
27791,27792,NADPH oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5253,27792,NADPH oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15913,27793,transglutaminase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26022,27794,DeltaF508-CFTR Correctors,MoA,Withdrawn,Gene,Chemical_Compound
7292,27799,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
7292,27800,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
9241,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27779,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
6843,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
12486,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
14335,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27805,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27806,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
14689,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
4626,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27807,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27808,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
3688,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
3768,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
6054,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
4647,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27809,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27810,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27811,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
6007,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27812,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
11693,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27813,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
10079,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
7041,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27814,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27815,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
4803,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
9719,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
14627,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27816,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
13320,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
7562,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27817,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27818,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
15709,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
8107,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
9595,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
6294,27804,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
25969,27820,tumor necrosis factor release inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14171,27822,immunophilin ligand,MoA,Preclinical,Gene,Chemical_Compound
13063,27823,NAMPT inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10758,27824,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5820,27824,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10758,27825,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5820,27825,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25937,27826,growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6074,27826,growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27434,27826,growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27789,27827,glucokinase inhibitor|protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4074,27827,glucokinase inhibitor|protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25843,27828,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25844,27828,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7247,27829,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26723,27829,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15425,27829,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27437,27829,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25738,27829,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9117,27830,ARF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,27831,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,27831,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5075,27834,BCL inhibitor|MCL1 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26367,27835,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14171,27836,FKBP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13063,27837,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25756,27838,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25849,27839,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25849,27840,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25519,27841,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25826,27842,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,27843,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25523,27843,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25524,27843,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25824,27843,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25825,27843,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,27843,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,27843,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,27843,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25933,27843,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27336,27844,integrin antagonist,MoA,Preclinical,Gene,Chemical_Compound
13890,27844,integrin antagonist,MoA,Preclinical,Gene,Chemical_Compound
27845,27846,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25568,27846,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
26739,27847,estrogen receptor agonist|FXR antagonist|progesterone receptor agonist,MoA,Launched,Gene,Chemical_Compound
8041,27848,adenosine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25697,27848,adenosine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25826,27853,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25524,27854,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8203,27855,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10968,27855,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13139,27856,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
8041,27857,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25697,27857,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9810,27857,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25698,27857,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
27292,27858,toll-like receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26288,27859,SYK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6474,27860,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27861,27862,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6474,27862,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9885,27863,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6999,27864,glycogen synthase kinase inhibitor|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,27864,glycogen synthase kinase inhibitor|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12385,27865,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25817,27866,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13343,27867,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,27867,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25887,27867,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26819,27867,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25779,27867,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27868,27869,glucose dependent insulinotropic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25605,27870,urotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,27871,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25523,27871,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25524,27871,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11330,27872,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,27872,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6218,27872,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26374,27872,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,27873,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
6218,27873,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
11481,27874,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3613,27874,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12367,27874,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7640,27875,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,27875,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6809,27875,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,27875,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25817,27875,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25976,27876,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6139,27877,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
4277,27878,fatty acid synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12168,27879,epoxide hydolase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27880,27881,bile acid transporter inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13343,27882,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,27882,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5297,27882,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3004,27883,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4204,27884,leucine rich repeat kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8717,27885,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27886,27885,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,27887,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13626,27888,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9902,27888,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11459,27889,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7691,27889,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11100,27890,histone lysine methyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10469,27891,protein phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9139,27892,lactate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9885,27893,histone lysine demethylase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25756,27894,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12385,27895,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13626,27896,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14636,27897,PLK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11100,27898,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,27899,serum/glucocorticoid regulated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14431,27899,serum/glucocorticoid regulated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,27900,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3613,27900,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12367,27900,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3944,27900,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2906,27900,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27901,27900,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25737,27900,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8196,27900,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5832,27900,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14109,27902,glucocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8838,27903,centromere associated protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5185,27904,FLT3 inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25603,27904,FLT3 inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25604,27904,FLT3 inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,27904,FLT3 inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25542,27905,cholinergic receptor agonist,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25913,27911,nitric oxide synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26978,27912,creatine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27914,27915,oxoeicosanoid receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
26787,27916,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27917,27916,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27918,27916,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27919,27916,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12385,27920,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25820,27921,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10141,27922,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5185,27923,cFMS kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26220,27924,elastase inhibitor|leukocyte elastase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9476,27925,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
11708,27925,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
25849,27926,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26739,27927,FXR agonist,MoA,Preclinical,Gene,Chemical_Compound
26728,27928,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25937,27929,growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8337,27930,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12385,27930,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25937,27931,leucine rich repeat kinase inhibitor|RAF inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5450,27931,leucine rich repeat kinase inhibitor|RAF inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26388,27932,calcium channel activator,MoA,Preclinical,Gene,Chemical_Compound
12907,27933,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,27933,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25833,27934,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8337,27935,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8337,27936,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26411,27937,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,27937,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2774,27937,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25926,27938,melanin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27939,27938,melanin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25849,27940,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14636,27941,PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15336,27941,PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25820,27942,free fatty acid receptor agonist|G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25756,27942,free fatty acid receptor agonist|G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13677,27943,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10141,27943,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9967,27943,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25963,27944,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25961,27944,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15548,27944,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25965,27944,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10758,27945,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5820,27945,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7800,27946,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,27946,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26780,27947,PKA inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12916,27947,PKA inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5770,27947,PKA inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15178,27948,autotaxin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25963,27949,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25963,27950,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8093,27955,phospholipase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3540,27955,phospholipase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7020,27961,monoamine oxidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7633,27961,monoamine oxidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5075,27962,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10608,27963,TRPA1 channel blocker,MoA,Phase 1,Gene,Chemical_Compound
6139,27964,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
4585,27965,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7592,27965,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5574,27965,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,27966,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25697,27966,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,27966,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25698,27966,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8285,27968,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6399,27969,ACAT inhibitor,MoA,Launched,Gene,Chemical_Compound
27970,27969,ACAT inhibitor,MoA,Launched,Gene,Chemical_Compound
8363,27969,ACAT inhibitor,MoA,Launched,Gene,Chemical_Compound
27971,27969,ACAT inhibitor,MoA,Launched,Gene,Chemical_Compound
8285,27972,flavanone glycoside,MoA,Launched,Gene,Chemical_Compound
25749,27972,flavanone glycoside,MoA,Launched,Gene,Chemical_Compound
25662,27974,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25553,27974,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,27974,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27054,27974,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11481,27975,AKT inhibitor|differentiation inducer|NFKB pathway inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25775,27982,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
14283,27984,GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,27985,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6929,27986,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14636,27987,PLK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25623,27992,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11142,27992,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4203,27992,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14160,27992,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14968,27992,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25766,27993,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7829,27993,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25636,27993,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7533,27994,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25932,27995,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6859,27996,acetylcholinesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12916,28012,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5770,28012,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,28012,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25806,28014,progesterone receptor agonist,MoA,Launched,Gene,Chemical_Compound
6859,28015,cholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7020,28018,monoamine oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7633,28018,monoamine oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7591,28020,aldose reductase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2742,28020,aldose reductase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,28021,IKK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25991,28021,IKK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25969,28021,IKK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10635,28022,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6078,28023,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28024,28023,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5999,28025,bromodomain inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14000,28025,bromodomain inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15528,28025,bromodomain inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5999,28026,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14000,28026,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15528,28026,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15636,28027,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12752,28028,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9531,28028,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,28029,adenosine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25697,28029,adenosine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
9810,28029,adenosine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25698,28029,adenosine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25668,28031,hydroxycarboxylic acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8041,28032,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26286,28032,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12939,28032,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7103,28032,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11214,28032,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27272,28032,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4153,28032,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26577,28032,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26578,28032,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25623,28033,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7449,28034,lipoprotein lipase activator,MoA,Phase 2,Gene,Chemical_Compound
14979,28041,growth hormone secretagogue receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25983,28041,growth hormone secretagogue receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25936,28043,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
2757,28043,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25936,28044,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25792,28045,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25794,28045,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
11214,28046,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11214,28047,PPAR receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
3188,28049,beta-catenin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25775,28050,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25889,28050,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25584,28051,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26884,28052,thromboxane receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26819,28053,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25722,28053,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25843,28053,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25844,28053,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25605,28053,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25889,28054,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25631,28055,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25775,28055,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
10608,28056,TRPV agonist,MoA,Phase 1,Gene,Chemical_Compound
25988,28056,TRPV agonist,MoA,Phase 1,Gene,Chemical_Compound
28057,28058,mucin production enhancer,MoA,Phase 3,Gene,Chemical_Compound
3188,28062,beta catenin inhibitor|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15679,28062,beta catenin inhibitor|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8901,28063,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10658,28063,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10045,28063,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14325,28063,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28064,28065,insulin sensitizer,MoA,Phase 1,Gene,Chemical_Compound
25933,28066,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
9986,28068,MDM inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8546,28068,MDM inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25512,28069,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25636,28069,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
27440,28071,"indoleamine 2,3-dioxygenase inhibitor",MoA,Preclinical,Gene,Chemical_Compound
25963,28072,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25961,28072,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
15548,28072,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25965,28072,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
7304,28073,XIAP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14020,28073,XIAP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25961,28074,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25963,28075,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,28076,adrenergic receptor antagonist|glutamate receptor antagonist,MoA,Launched,Gene,Chemical_Compound
14233,28078,sigma receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8456,28080,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,28081,IKK inhibitor|SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,28082,IKK inhibitor|NFkB pathway inhibitor,MoA,Phase 1,Gene,Chemical_Compound
28083,28084,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26274,28084,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26029,28084,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25655,28084,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26030,28084,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3464,28084,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3521,28084,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11446,28084,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26276,28084,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25573,28084,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25585,28088,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25932,28088,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25512,28091,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25514,28091,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25585,28095,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25932,28095,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25585,28096,histamine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25585,28097,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10745,28098,c-Met inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6495,28099,calcineurin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26427,28100,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25771,28102,selective serotonin reuptake inhibitor (SSRI),MoA,Withdrawn,Gene,Chemical_Compound
7020,28104,norepinephrine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7633,28104,norepinephrine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15076,28105,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8337,28105,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12385,28105,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10141,28105,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25569,28107,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
15298,28108,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
6044,28108,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
6999,28108,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
15298,28109,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,28109,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,28109,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28110,28109,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,28109,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10748,28111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7555,28111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25646,28111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25647,28111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26652,28111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25649,28111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26653,28111,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6024,28114,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 2/Phase 3,Gene,Chemical_Compound
28116,28117,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
26200,28117,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
7829,28117,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25636,28117,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
27440,28119,"indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 2,Gene,Chemical_Compound
9407,28122,Hec1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,28123,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13754,28124,neurotrophic agent,MoA,Launched,Gene,Chemical_Compound
10635,28124,neurotrophic agent,MoA,Launched,Gene,Chemical_Compound
26367,28126,FXR agonist,MoA,Phase 1,Gene,Chemical_Compound
6567,28127,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
28128,28127,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
25585,28130,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25932,28130,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26022,28131,CFTR channel antagonist,MoA,Phase 2,Gene,Chemical_Compound
15280,28132,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4020,28132,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7816,28132,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6474,28132,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15280,28133,hypoxia inducible factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12416,28133,hypoxia inducible factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7290,28133,hypoxia inducible factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7178,28134,p21 activated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6859,28135,acetylcholinesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7020,28138,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7633,28138,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25522,28139,serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
6150,28142,endothelin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25647,28143,steroid sulfatase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8338,28143,steroid sulfatase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25522,28145,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25523,28145,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25779,28146,cytochrome P450 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10043,28147,macrophage migration inhibiting factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28148,28149,gene expression stimulant,MoA,Phase 2,Gene,Chemical_Compound
28150,28149,gene expression stimulant,MoA,Phase 2,Gene,Chemical_Compound
25569,28156,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25611,28156,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25612,28156,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25571,28156,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25613,28156,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25614,28156,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27726,28156,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27727,28156,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27728,28156,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13139,28157,guanylate cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
7829,28165,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25636,28165,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
15188,28167,kinesin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4968,28169,eukaryotic translation initiation factor inhibitor|PERK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8717,28169,eukaryotic translation initiation factor inhibitor|PERK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10693,28170,ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28172,28173,neural stem cell inducer,MoA,Preclinical,Gene,Chemical_Compound
3105,28174,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28175,28176,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6024,28177,aryl hydrocarbon receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12646,28178,phosphodiesterase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
8419,28180,GEF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25865,28181,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8301,28182,ubiquitin C-terminal hydrolase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4919,28190,porcupine inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,28192,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25843,28193,opioid receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25929,28194,dopamine reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28195,28196,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8514,28197,gamma secretase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25932,28198,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25680,28199,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25682,28199,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26967,28200,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25856,28201,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6190,28202,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
9570,28203,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26304,28203,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26305,28203,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9941,28203,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5184,28203,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11348,28203,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11002,28203,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15499,28203,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26306,28203,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11646,28203,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3799,28203,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9986,28203,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26427,28204,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25518,28205,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10745,28206,tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26396,28207,glutamate receptor positive allosteric modulator,MoA,Phase 2,Gene,Chemical_Compound
2969,28208,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25856,28209,FAAH inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25540,28210,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28211,28212,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13343,28213,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,28213,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,28213,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,28213,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25932,28214,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15528,28215,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28216,28215,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26265,28217,opioid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
28218,28219,lysophospholipid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6723,28219,lysophospholipid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28220,28221,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25991,28221,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6026,28221,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25969,28221,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25849,28222,cannabinoid receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
7800,28223,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,28223,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14681,28224,monoacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6350,28225,WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8267,28225,WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,28225,WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7800,28226,tankyrase inhibitor|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,28226,tankyrase inhibitor|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,28227,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14681,28228,monoacylglucerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25856,28229,FAAH inhibitor|monoacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14681,28229,FAAH inhibitor|monoacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5261,28230,K-Ras inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10693,28231,ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15188,28232,kinesin-like spindle protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2742,28233,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
28234,28233,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25766,28233,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
7292,28233,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
3148,28233,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
6843,28233,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
3557,28233,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
28235,28233,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25963,28236,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8327,28236,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11784,28236,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28237,28236,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28238,28236,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28239,28236,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15946,28240,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5849,28241,chondrocyte differentiation stimulator,MoA,Preclinical,Gene,Chemical_Compound
12796,28242,sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28243,28242,sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26763,28242,sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7510,28242,sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,28244,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15883,28245,neprilysin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12616,28246,ACAT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9763,28246,ACAT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9902,28247,rho associated kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8870,28248,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,28248,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,28248,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,28248,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25642,28255,P selectin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9018,28256,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25603,28256,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25604,28256,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,28256,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3181,28257,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8529,28257,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8328,28257,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28258,28259,hexokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3213,28260,neural stem cell inducer,MoA,Preclinical,Gene,Chemical_Compound
6078,28261,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28024,28261,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5185,28262,c-Fms inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,28262,c-Fms inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25604,28262,c-Fms inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,28262,c-Fms inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,28263,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3823,28264,mannosidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9932,28264,mannosidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25906,28265,lipoprotein antagonist,MoA,Preclinical,Gene,Chemical_Compound
6138,28266,proteasome inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10945,28266,proteasome inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14681,28267,monoacylglucerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14776,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7517,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26411,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15365,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25879,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15947,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4449,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9097,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25540,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7247,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13626,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8554,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4757,28268,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14776,28269,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25702,28270,BCRP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10012,28270,BCRP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6777,28271,exportin antagonist,MoA,Preclinical,Gene,Chemical_Compound
6777,28272,exportin antagonist,MoA,Preclinical,Gene,Chemical_Compound
11330,28273,ALK inihibitor,MoA,Preclinical,Gene,Chemical_Compound
26149,28274,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26150,28274,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,28274,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27034,28275,BCRP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,28276,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12946,28277,ATM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,28277,ATM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12946,28278,ATM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28279,28280,ribosyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10758,28281,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13343,28281,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,28281,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25603,28281,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8041,28282,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25697,28282,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
9810,28282,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25698,28282,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
15786,28283,SRC inhibitor|tubulin polymerization inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26522,28284,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25623,28284,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
11142,28284,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4203,28284,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
8468,28285,WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11792,28286,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6510,28287,sphingosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10880,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
28299,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
13125,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
28300,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
11401,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
28301,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
5008,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
28296,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
6083,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
12291,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
12475,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
5394,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
13075,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
14016,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
25623,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
11142,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
4203,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
14160,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
14968,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
26071,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
9924,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
26849,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
3815,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
10120,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
7790,28298,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
26967,28312,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25626,28312,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6054,28312,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28313,28312,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14014,28312,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14374,28312,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28316,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
6861,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2925,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
10326,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11401,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7521,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
4898,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28318,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2589,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8536,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28319,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8684,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28320,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2782,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28321,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28322,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28323,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
9646,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
13611,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7658,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15155,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
10125,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28324,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11430,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26921,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
13753,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
12570,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
13075,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14016,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28290,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
5063,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25963,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25961,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15548,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25965,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15187,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28325,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8327,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11784,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28237,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28238,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28239,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25623,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11142,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
4203,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14160,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14968,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25624,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25625,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26967,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26396,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26832,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
27201,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26833,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25951,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26834,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28326,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14532,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28327,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28328,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2954,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28329,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
9072,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
3815,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26843,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
6594,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28330,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28331,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15919,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28332,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25664,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28333,28317,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26194,28337,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3528,28337,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8505,28337,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28338,28337,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28293,28337,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28294,28337,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
27278,28340,dopamine beta hydroxylase inhibitor|eukaryotic translation initiation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9361,28340,dopamine beta hydroxylase inhibitor|eukaryotic translation initiation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26412,28341,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25913,28341,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26109,28342,nitric oxide synthase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26412,28343,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25913,28343,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26109,28343,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8684,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
10639,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14975,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8094,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7185,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
6651,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7415,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28345,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14905,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7916,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2649,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
5611,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
4036,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15632,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28346,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28347,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26932,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8687,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28348,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28349,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28350,28344,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28320,28351,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25961,28351,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8327,28351,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11784,28351,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26967,28351,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26396,28351,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26832,28351,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25626,28351,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25951,28351,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26834,28351,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26728,28353,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25833,28354,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12385,28355,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28356,28357,glucagon receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26338,28358,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26340,28358,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
27109,28358,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25561,28359,oxytocin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26124,28359,oxytocin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26125,28359,oxytocin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25569,28360,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25611,28360,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25612,28360,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25613,28360,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25619,28360,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
7153,28361,thromboxane receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25623,28362,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,28362,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,28362,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,28362,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14968,28362,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7457,28363,inositol monophosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25518,28364,sigma receptor agonist|sigma receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14233,28364,sigma receptor agonist|sigma receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,28365,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25523,28365,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,28365,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25623,28366,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25623,28367,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,28367,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,28367,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,28367,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14968,28367,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12473,28368,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25568,28368,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
12473,28369,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25519,28370,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25520,28370,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25792,28370,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25794,28370,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25517,28371,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25518,28371,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25519,28371,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25520,28371,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,28371,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,28371,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25933,28371,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25934,28371,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25631,28372,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25775,28372,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25889,28372,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12473,28373,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
3325,28374,farnesyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9265,28374,farnesyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10206,28374,farnesyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7320,28375,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25569,28376,GABA receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25611,28376,GABA receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25612,28376,GABA receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25613,28376,GABA receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
28385,28386,immunosuppressant,MoA,Phase 3,Gene,Chemical_Compound
25937,28388,tropomyosin receptor kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
6074,28388,tropomyosin receptor kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
27434,28388,tropomyosin receptor kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
13040,28391,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25933,28391,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
28392,28393,actin polymerization inhibitor,MoA,Phase 1,Gene,Chemical_Compound
28394,28393,actin polymerization inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3535,28393,actin polymerization inhibitor,MoA,Phase 1,Gene,Chemical_Compound
28395,28396,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
28397,28396,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
26116,28396,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
11407,28396,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
27223,28396,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
14448,28396,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
7633,28398,monoamine oxidase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4198,28399,XIAP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8344,28399,XIAP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6399,28400,diacylglycerol O acyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4293,28401,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26448,28401,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9785,28401,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26780,28402,haspin kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10758,28403,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12119,28403,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4774,28403,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15913,28404,tissue transglutaminase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12119,28405,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2805,28405,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14201,28406,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25680,28408,orexin receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25682,28408,orexin receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25567,28412,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25603,28415,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25937,28415,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14648,28417,nitric oxide production inhibitor|tau aggregation inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12456,28421,acetylcholine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
27108,28422,potassium channel activator,MoA,Phase 3,Gene,Chemical_Compound
25563,28425,acetylcholine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
13040,28439,histamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25607,28445,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4919,28446,porcupine inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10658,28447,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25911,28448,cytochrome P450 inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
28449,28448,cytochrome P450 inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25633,28450,voltage-gated sodium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
4909,28451,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25766,28452,cyclooxygenase inhibitor|lipoxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25920,28452,cyclooxygenase inhibitor|lipoxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25636,28452,cyclooxygenase inhibitor|lipoxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25969,28455,tumor necrosis factor production inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2722,28457,LIM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12844,28463,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5185,28463,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26149,28463,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25603,28463,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26150,28463,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25683,28463,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25604,28463,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,28463,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4171,28463,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15295,28463,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4155,28464,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
25820,28464,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
25756,28464,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
28397,28464,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
12087,28464,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
10141,28464,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
25988,28464,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
25936,28465,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
2757,28465,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
26345,28465,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
5524,28465,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
11627,28466,IGF-1 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6218,28466,IGF-1 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28467,28466,IGF-1 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26367,28474,FXR antagonist|vitamin D receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26739,28474,FXR antagonist|vitamin D receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26890,28474,FXR antagonist|vitamin D receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6126,28474,FXR antagonist|vitamin D receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15188,28475,kinesin-like spindle protein inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26124,28476,vasopressin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
6074,28477,tropomyosin receptor kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15753,28478,survival motor neuron protein modulator,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11348,28479,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11002,28479,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28480,28481,neurotrophic agent,MoA,Phase 1,Gene,Chemical_Compound
4522,28484,O6-alkylguanine-DNA alkyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11542,28486,glycinamide ribonucleotide formyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3325,28488,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7848,28488,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5261,28488,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14746,28488,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27789,28489,glucokinase inhibitor,MoA,Launched,Gene,Chemical_Compound
25616,28493,benzodiazepine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
15774,28493,benzodiazepine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25569,28494,GABA receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
26338,28495,CCK receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26340,28495,CCK receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4449,28499,p38 MAPK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2744,28503,cysteine peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28505,28506,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4204,28507,leucine rich repeat kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25626,28508,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
28509,28510,leukocyte activator,MoA,Phase 2,Gene,Chemical_Compound
28057,28510,leukocyte activator,MoA,Phase 2,Gene,Chemical_Compound
25697,28511,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7896,28513,endonuclease inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15946,28513,endonuclease inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12989,28513,endonuclease inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5212,28514,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26149,28514,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25683,28514,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25604,28514,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7392,28514,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12302,28514,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4171,28514,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25697,28515,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,28515,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25518,28517,dopamine receptor modulator|serotonin receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25525,28517,dopamine receptor modulator|serotonin receptor antagonist,MoA,Launched,Gene,Chemical_Compound
7829,28519,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25636,28519,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
28064,28520,sodium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
15946,28522,glucosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25754,28523,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25755,28523,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7292,28524,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
9476,28524,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
11708,28524,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
26890,28524,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
14109,28524,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
27581,28525,tryptophan hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7284,28526,LIM kinase inhibitor|rho associated kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13626,28526,LIM kinase inhibitor|rho associated kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9902,28526,LIM kinase inhibitor|rho associated kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25847,28527,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8086,28529,glycogen synthase kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2774,28530,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28175,28530,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26832,28531,glutamate receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25963,28532,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25961,28532,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15548,28532,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25965,28532,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
8327,28532,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
2774,28533,TGF beta receptor inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25856,28534,FAAH inhibitor|FAAH reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,28535,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28509,28536,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26340,28537,CCK receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11061,28538,glycine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7292,28539,androgen receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
28509,28540,leukotriene receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28057,28540,leukotriene receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8554,28541,ribosomal protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7517,28542,CHK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7517,28543,CHK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27789,28544,glucokinase activator,MoA,Phase 2,Gene,Chemical_Compound
7079,28545,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11600,28546,JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5775,28546,JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,28547,MET inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6908,28548,beta-secretase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11699,28549,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5212,28550,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
25730,28550,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
25731,28550,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
26199,28550,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
25683,28550,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
26340,28551,CCK receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6908,28552,beta-secretase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11481,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25879,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2676,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14636,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,28553,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26396,28554,glutamate receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
5876,28555,cathepsin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9018,28556,RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5450,28556,RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7640,28557,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5999,28558,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14000,28558,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15528,28558,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25524,28559,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25847,28560,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,28561,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25523,28561,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,28561,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25824,28561,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25825,28561,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25525,28561,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7079,28561,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,28561,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25934,28561,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
2774,28562,p38 MAPK inhibitor|TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25523,28563,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25524,28563,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,28563,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,28563,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25963,28564,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25961,28564,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
15548,28564,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25965,28564,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26967,28565,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25567,28566,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26163,28566,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27109,28567,ATP-sensitive potassium channel antagonist,MoA,Phase 2,Gene,Chemical_Compound
26154,28568,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27005,28568,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10922,28568,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28569,28570,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
14239,28570,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
11575,28570,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
6524,28570,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
4602,28570,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
11646,28571,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25569,28575,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10141,28575,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25690,28581,cytomegalovirus inhibitor|protein kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26029,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28583,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28584,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25655,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26030,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3464,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28585,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6064,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15396,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3439,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3521,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28586,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13508,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28587,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6244,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27586,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28588,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28589,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13470,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11446,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28590,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26276,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25573,28582,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25843,28594,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25626,28595,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26016,28597,glucose dependent insulinotropic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28602,28603,NOD like receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26265,28604,nociceptin/orphanin FQ receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25522,28605,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25524,28605,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25824,28605,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25525,28605,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7079,28605,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25526,28605,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25933,28605,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
9941,28606,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28607,28608,NFkB pathway inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10933,28609,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25525,28610,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7079,28610,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25526,28610,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25700,28611,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,28612,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25522,28613,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
5938,28614,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28618,28619,neurotensin receptor antagonist,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
28429,28619,neurotensin receptor antagonist,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25820,28623,ATP citrase lyase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26427,28629,potassium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
6599,28630,HMGCR inhibitor,MoA,Launched,Gene,Chemical_Compound
8551,28631,STAT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15643,28632,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7902,28641,hypoxia inducible factor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15155,28648,vitamin K,MoA,Phase 2,Gene,Chemical_Compound
3520,28648,vitamin K,MoA,Phase 2,Gene,Chemical_Compound
2720,28648,vitamin K,MoA,Phase 2,Gene,Chemical_Compound
10485,28650,MALT1 inhibitor (JH),MoA,Phase 2,Gene,Chemical_Compound
12989,28657,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9570,28659,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9941,28659,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13152,28660,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25525,28665,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7079,28665,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25526,28665,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25567,28665,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26163,28665,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25933,28665,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25934,28665,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7829,28667,cyclooxygenase inhibitor|opioid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
10758,28670,Bcr-Abl kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5820,28670,Bcr-Abl kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25544,28671,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25722,28672,immunostimulant,MoA,Phase 2,Gene,Chemical_Compound
6859,28676,acetylcholinesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13040,28678,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
7591,28683,angiotensin converting enzyme inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7896,28689,DNA repair enzyme inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25563,28697,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25542,28701,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,28708,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25523,28708,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25524,28708,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25824,28708,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25825,28708,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25525,28708,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
7079,28708,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25526,28708,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25527,28708,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25933,28708,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25934,28708,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
7829,28714,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
25636,28714,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
6859,28715,acetylcholinesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6599,28718,HMGCR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5938,28720,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25911,28721,estrogen receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25803,28721,estrogen receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
8970,28722,proteasome inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25542,28723,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4293,28724,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10745,28724,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12460,28725,PI4K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25963,28727,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
27351,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
15539,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25942,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25943,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25588,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25590,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25591,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25944,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
12340,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
12318,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
16027,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
8733,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25829,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
3489,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25831,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25832,28728,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
11142,28730,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4203,28730,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14160,28730,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14968,28730,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
10141,28733,PPAR receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7633,28736,monoamine oxidase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4266,28740,DNA replication inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6708,28740,DNA replication inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26195,28740,DNA replication inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26053,28740,DNA replication inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6859,28741,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25563,28741,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25517,28741,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25518,28741,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25525,28741,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7079,28741,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25526,28741,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7020,28741,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25771,28741,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
28745,28746,MRE11A exonuclease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28751,28752,antitumor agent,MoA,Phase 2,Gene,Chemical_Compound
25847,28758,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15875,28759,niacin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25668,28759,niacin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7292,28760,androgen receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
26427,28761,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
28356,28762,glucagon receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
5030,28763,WEE1 kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11481,28764,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3613,28764,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12367,28764,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6190,28765,TRPV antagonist,MoA,Phase 2,Gene,Chemical_Compound
5212,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25730,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25731,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26149,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25603,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26150,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25683,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26448,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10745,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26449,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25937,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6074,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12302,28766,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25833,28767,prostaglandin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26380,28768,calcitonin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25682,28769,orexin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
28770,28771,bombesin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27868,28771,bombesin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28772,28771,bombesin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13343,28773,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,28773,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25887,28773,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14354,28774,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26815,28774,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25680,28775,orexin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25682,28775,orexin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10745,28776,c-Met inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4180,28777,stearoyl-CoA desaturase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13343,28778,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6554,28779,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,28780,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,28780,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12097,28780,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25817,28780,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,28781,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13343,28782,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25567,28783,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
26163,28783,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25826,28783,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
2512,28784,GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4445,28785,CLK inhibitor|DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13005,28785,CLK inhibitor|DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28786,28787,liver receptor homolog inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25853,28788,G protein-coupled receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9770,28789,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
26763,28789,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
26345,28790,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25588,28791,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25590,28791,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25591,28791,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
7902,28792,hypoxia inducible factor activator,MoA,Preclinical,Gene,Chemical_Compound
27109,28793,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
3384,28794,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28795,28796,inward rectifier potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
3540,28797,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28618,28798,neurotensin agonist,MoA,Preclinical,Gene,Chemical_Compound
13830,28799,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8621,28800,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25779,28801,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25879,28801,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,28801,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,28801,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12119,28802,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25704,28802,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2805,28802,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14788,28803,lysophospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8372,28804,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25987,28804,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9018,28805,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5450,28805,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7510,28806,myosin light chain kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6665,28807,retinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,28808,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7800,28809,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9570,28810,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26305,28810,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9941,28810,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5184,28810,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7020,28813,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7633,28813,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13964,28815,hypoxia inducible factor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15188,28820,kinesin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25697,28824,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,28824,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4277,28824,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13264,28824,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28413,28824,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6034,28825,other antibiotic,MoA,Launched,Gene,Chemical_Compound
26149,28827,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26150,28827,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25683,28827,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25604,28827,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28094,28828,toll-like receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26967,28832,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27201,28832,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25626,28832,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28833,28834,mitotic kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28833,28835,monopolar spindle 1 kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28833,28836,monopolar spindle 1 kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15890,28837,thromboxane synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25569,28838,GABA receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25611,28838,GABA receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25612,28838,GABA receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25613,28838,GABA receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
7625,28839,gamma secretase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9810,28840,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25698,28840,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25698,28841,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28842,28843,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8041,28844,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25697,28844,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,28844,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25698,28844,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25865,28845,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26396,28846,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26832,28846,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12907,28847,protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,28847,protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25569,28848,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25611,28848,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25612,28848,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25571,28848,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25613,28848,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25614,28848,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
27726,28848,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
27727,28848,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
27728,28848,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
11214,28849,phosphodiesterase inhibitor|platelet aggregation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,28852,androgen receptor agonist|cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26412,28853,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,28853,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25988,28854,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
25932,28857,histamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
4585,28858,ubiquitin ligase transport promoter,MoA,Preclinical,Gene,Chemical_Compound
15252,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
3984,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
4215,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
8154,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
3936,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
3311,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
15147,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
6599,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
3557,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
5503,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
11666,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
25629,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
25711,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
6943,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
26051,28860,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
25518,28863,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25519,28863,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,28863,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25843,28872,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25844,28872,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25722,28874,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25843,28874,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25844,28874,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25722,28875,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25843,28875,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25844,28875,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,28876,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13991,28876,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25546,28876,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25522,28876,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25825,28876,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8551,28877,STAT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25911,28881,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
3148,28881,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
25596,28881,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
6843,28881,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
3557,28881,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
28883,28884,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25523,28885,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26340,28886,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25797,28888,voltage-gated sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
28116,28889,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26200,28889,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
5075,28890,BCL inhibitor,MoA,Phase 2,Gene,Chemical_Compound
16033,28890,BCL inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13520,28890,BCL inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26005,28891,corticotropin releasing factor receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25876,28892,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25963,28893,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25961,28893,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15548,28893,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25965,28893,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8327,28893,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25623,28893,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,28893,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,28893,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13139,28894,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25531,28894,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13784,28894,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7612,28895,complement antagonist,MoA,Preclinical,Gene,Chemical_Compound
14233,28896,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25563,28898,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
8041,28899,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
25697,28899,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
9810,28899,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
25698,28899,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
5513,28900,RIPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4774,28901,necroptosis inhibitor|RIPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25544,28904,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13991,28904,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25512,28904,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25779,28904,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25522,28904,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25525,28904,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25526,28904,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25892,28904,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25929,28904,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25771,28904,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25563,28905,acetylcholine receptor agonist|benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
15946,28909,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12989,28909,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27278,28913,dopamine beta hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28917,28918,neural stem cell inducer,MoA,Preclinical,Gene,Chemical_Compound
9873,28918,neural stem cell inducer,MoA,Preclinical,Gene,Chemical_Compound
9570,28920,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15499,28920,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3844,28921,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26412,28922,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25913,28922,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26109,28922,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25519,28923,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25520,28924,dopamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26005,28925,corticotropin releasing factor receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9139,28926,lactate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14470,28927,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12654,28927,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11225,28927,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7628,28929,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7020,28929,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7633,28929,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25847,28937,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25631,28939,adrenergic receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25775,28939,adrenergic receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25544,28944,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25892,28953,norepinephrine reuptake inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25929,28953,norepinephrine reuptake inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25771,28953,norepinephrine reuptake inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7628,28954,catechol O methyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25563,28956,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11871,28959,nuclear factor erythroid derived|like (NRF2) activator,MoA,Preclinical,Gene,Chemical_Compound
12009,28960,adenylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27440,28961,"indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 1,Gene,Chemical_Compound
25623,28962,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11142,28962,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4203,28962,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14160,28962,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14968,28962,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25603,28963,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14636,28963,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26377,28963,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15336,28963,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11104,28964,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4689,28965,glucosidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27918,28966,GABA uptake inhibitor|GAT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25829,28967,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
3489,28967,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25831,28967,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25832,28967,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26265,28968,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14233,28969,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26787,28969,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25636,28970,cyclooxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14717,28971,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27817,28972,tubulin polymerization inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14652,28973,thymidylate synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25518,28975,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25892,28975,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25929,28975,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25722,28977,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25843,28977,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25844,28977,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,28984,selective serotonin reuptake inhibitor (SSRI),MoA,Phase 1,Gene,Chemical_Compound
10141,28990,ICAM1 antagonist,MoA,Phase 2,Gene,Chemical_Compound
27351,28991,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10885,28991,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
12435,28991,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10608,28991,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26582,28992,calcium receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26728,28993,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12018,28994,caspase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3105,28995,JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11600,28995,JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5775,28995,JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10662,28995,JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
14707,28996,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25926,28997,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27105,28997,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
14707,28997,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
14707,28998,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
26388,28999,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27146,28999,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27148,28999,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
13006,28999,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25926,29000,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25553,29001,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27055,29001,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10082,29002,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
14707,29003,potassium channel agonist,MoA,Phase 2,Gene,Chemical_Compound
26388,29004,calcium-activated potassium channel modulator,MoA,Preclinical,Gene,Chemical_Compound
27146,29004,calcium-activated potassium channel modulator,MoA,Preclinical,Gene,Chemical_Compound
27148,29004,calcium-activated potassium channel modulator,MoA,Preclinical,Gene,Chemical_Compound
25555,29005,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
9570,29006,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26029,29007,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25690,29008,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25562,29009,CC chemokine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8227,29010,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5659,29010,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8812,29011,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13830,29011,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29012,29011,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15642,29011,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8621,29013,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4628,29013,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29014,29015,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3033,29015,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29016,29015,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15410,29017,ubiquitin-conjugating enzyme inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29014,29018,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3033,29018,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25555,29019,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25837,29019,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26728,29020,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28429,29021,neurotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10141,29022,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11627,29023,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,29024,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9645,29025,cyclin D inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29025,cyclin D inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9645,29026,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29026,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,29027,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,29028,DNA dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9986,29029,MDM inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8546,29029,MDM inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,29030,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,29031,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6218,29031,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4229,29032,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4111,29032,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15816,29033,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7640,29033,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9637,29033,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12097,29033,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25817,29033,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5212,29034,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25730,29034,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25731,29034,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26199,29034,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25683,29034,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6383,29035,ephrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11600,29036,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10745,29037,MET inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7351,29038,dipeptidyl peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4229,29039,HSP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4111,29039,HSP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9052,29040,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11330,29041,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6218,29041,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,29042,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3964,29043,ceramidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7178,29044,p21 activated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,29045,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25697,29045,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,29045,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25698,29045,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12154,29045,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8835,29046,alcohol dehydrogenase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
29048,29049,Oct activator,MoA,Preclinical,Gene,Chemical_Compound
5075,29050,BCL inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8551,29053,STAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25569,29054,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25611,29054,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25612,29054,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25613,29054,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
14011,29055,trace amine associated receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27461,29055,trace amine associated receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26172,29060,CRTH receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
5877,29061,cathepsin inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14710,29062,guanylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26282,29062,guanylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26284,29062,guanylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14470,29063,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9885,29064,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12594,29065,WDR5/MLL interaction inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26016,29068,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
25934,29069,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27223,29069,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26367,29070,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25847,29071,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26016,29071,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25853,29071,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8337,29071,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5193,29072,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
29073,29074,ATP synthase inhibitor|ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,29078,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29078,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,29078,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,29078,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14671,29085,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 3,Gene,Chemical_Compound
25847,29086,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
26016,29086,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
6190,29086,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
7591,29087,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15883,29087,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26016,29089,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29090,29091,cardiac myosin activator,MoA,Phase 3,Gene,Chemical_Compound
7087,29094,AKT inhibitor|MAP kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25833,29096,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25607,29097,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26276,29098,matrix metalloprotease inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25761,29099,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5659,29100,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7533,29100,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,29100,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25561,29101,vasopressin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26124,29101,vasopressin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26125,29101,vasopressin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7628,29102,catechol O methyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7628,29103,catechol O methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,29104,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8285,29104,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12907,29104,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5212,29104,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25730,29104,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25683,29104,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7392,29104,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,29104,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28471,29105,angiotensin converting enzyme inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25525,29106,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7079,29106,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25526,29106,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7731,29107,glycine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26197,29107,glycine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25847,29108,cannabinoid receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25512,29109,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
5075,29110,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26194,29113,NFkB pathway modulator,MoA,Launched,Gene,Chemical_Compound
26265,29115,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25844,29115,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25581,29116,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9885,29117,histone lysine demethylase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25522,29120,serotonin receptor agonist,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
7640,29121,mTOR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12907,29122,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26149,29123,KIT inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25683,29123,KIT inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25604,29123,KIT inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7292,29126,androgen receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25561,29127,oxytocin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26125,29127,oxytocin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14011,29128,coagulation factor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25563,29129,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25564,29129,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25565,29129,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25566,29129,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
9280,29129,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12500,29131,maternal embryonic leucine zipper kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5999,29132,bromodomain inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
14000,29132,bromodomain inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15528,29132,bromodomain inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13626,29134,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9902,29134,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15528,29138,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8215,29139,carnitine palmitoyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
29140,29139,carnitine palmitoyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25563,29142,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25564,29142,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25565,29142,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25566,29142,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25563,29143,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25564,29143,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25565,29143,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25566,29143,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25803,29150,xanthine oxidase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
27042,29154,sphingosine 1-phosphate receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
29048,29155,Oct inducer,MoA,Preclinical,Gene,Chemical_Compound
4522,29156,O6-alkylguanine-DNA alkyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9967,29157,retinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12018,29158,caspase activator,MoA,Phase 1,Gene,Chemical_Compound
8365,29160,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25603,29161,FLT3 inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3105,29161,FLT3 inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11600,29161,FLT3 inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5775,29161,FLT3 inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25779,29164,dopamine synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25849,29165,cannabinoid receptor agonist,MoA,Launched,Gene,Chemical_Compound
26016,29165,cannabinoid receptor agonist,MoA,Launched,Gene,Chemical_Compound
25853,29165,cannabinoid receptor agonist,MoA,Launched,Gene,Chemical_Compound
7640,29166,AKT inhibitor|mTOR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25605,29168,urotensin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6665,29169,retinoid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25518,29174,dopamine receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7762,29179,tubulin polymerization inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25518,29180,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25519,29180,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25520,29180,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25522,29180,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25934,29180,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
9570,29185,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,29186,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3844,29186,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25586,29191,platelet activating factor receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9570,29192,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9941,29192,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5184,29192,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15499,29192,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25607,29193,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9570,29194,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26304,29194,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15499,29194,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11646,29194,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11455,29195,potassium channel activator,MoA,Phase 1,Gene,Chemical_Compound
14717,29196,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25566,29197,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25926,29198,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
26230,29199,angiotensin antagonist,MoA,Phase 1,Gene,Chemical_Compound
25518,29200,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25519,29200,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12907,29201,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25683,29201,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5173,29202,endothelin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6150,29202,endothelin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12907,29203,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27363,29204,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5212,29205,FGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,29206,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5212,29206,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,29206,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14819,29206,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,29206,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5030,29206,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26030,29207,collagenase inhibitor|metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3521,29207,collagenase inhibitor|metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11446,29207,collagenase inhibitor|metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25518,29208,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12907,29209,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,29209,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,29209,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25518,29210,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25520,29210,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5212,29211,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25730,29211,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25731,29211,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26199,29211,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26149,29211,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26150,29211,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,29211,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7392,29211,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,29211,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25749,29212,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
14717,29213,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13225,29213,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4029,29213,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14717,29214,MAP kinase inhibitor|MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15643,29214,MAP kinase inhibitor|MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5030,29215,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,29216,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11481,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25879,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5450,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,29217,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26571,29218,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25856,29219,FAAH activator,MoA,Preclinical,Gene,Chemical_Compound
29220,29221,programmed death ligand inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25525,29224,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
12907,29225,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2744,29235,aspartic protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6901,29235,aspartic protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4497,29235,aspartic protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25800,29235,aspartic protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9967,29236,retinoid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25544,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
13991,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25546,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25512,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25514,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25515,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25517,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25518,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25519,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25520,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25521,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25522,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25523,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25524,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25525,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
7079,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25526,29237,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
11481,29239,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3325,29240,apoptosis stimulant|farnesyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7591,29242,angiotensin converting enzyme inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25623,29245,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11142,29245,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
4203,29245,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
12018,29246,caspase activator,MoA,Preclinical,Gene,Chemical_Compound
6963,29247,nedd activating enzyme inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10149,29247,nedd activating enzyme inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5185,29248,tyrosine kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
25603,29248,tyrosine kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
25604,29248,tyrosine kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
4449,29249,MAP kinase inhibitor|TIE tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15295,29249,MAP kinase inhibitor|TIE tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26571,29250,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11214,29251,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3944,29252,p21 activated kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13343,29253,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,29253,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10745,29254,c-Met inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9776,29255,prostaglandin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26578,29256,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25856,29257,FAAH inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6399,29258,diacylglycerol O acyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7640,29259,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,29259,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25549,29260,voltage-gated sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
27789,29261,glucokinase activator,MoA,Phase 2,Gene,Chemical_Compound
25983,29262,growth hormone secretagogue receptor inverse agonist,MoA,Phase 2,Gene,Chemical_Compound
7640,29263,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,29263,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4204,29264,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25561,29266,oxytocin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26125,29266,oxytocin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25856,29267,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10446,29268,SREBP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9052,29269,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14351,29269,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29270,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,29271,CHK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8332,29271,CHK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10658,29272,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10045,29272,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25779,29273,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10922,29274,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9052,29275,focal adhesion kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14351,29275,focal adhesion kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15298,29276,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29276,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5178,29276,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,29276,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,29276,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10658,29277,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10045,29277,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25856,29278,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15178,29279,autotaxin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7333,29280,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15528,29281,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2612,29282,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5325,29282,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12654,29283,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4791,29284,phosphofructokinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4791,29285,phosphofructokinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13493,29286,JNK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9097,29286,JNK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3775,29286,JNK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25879,29287,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,29287,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25542,29288,nicotinic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10745,29289,c-Met inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,29290,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,29290,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25887,29290,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,29291,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29291,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,29292,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8227,29292,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5659,29292,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6044,29292,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5178,29292,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11699,29292,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8227,29293,CDK inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5659,29293,CDK inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5178,29293,CDK inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25937,29293,CDK inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26967,29294,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27201,29294,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7829,29296,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
14620,29300,anticancer agent,MoA,Phase 2,Gene,Chemical_Compound
11455,29301,AMPK activator,MoA,Withdrawn,Gene,Chemical_Compound
13924,29301,AMPK activator,MoA,Withdrawn,Gene,Chemical_Compound
28943,29306,indicator dye,MoA,Withdrawn,Gene,Chemical_Compound
6859,29309,acetylcholinesterase inhibitor|beta amyloid synthesis inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7382,29309,acetylcholinesterase inhibitor|beta amyloid synthesis inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6738,29311,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
7829,29311,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25636,29311,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
8546,29315,p53 stabilizing agent,MoA,Preclinical,Gene,Chemical_Compound
29316,29317,sodium/glucose cotransporter inhibitor,MoA,Launched,Gene,Chemical_Compound
7734,29317,sodium/glucose cotransporter inhibitor,MoA,Launched,Gene,Chemical_Compound
26095,29317,sodium/glucose cotransporter inhibitor,MoA,Launched,Gene,Chemical_Compound
25993,29318,sodium/glucose cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29319,29318,sodium/glucose cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26591,29318,sodium/glucose cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7994,29318,sodium/glucose cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6024,29320,aryl hydrocarbon receptor ligand,MoA,Phase 1,Gene,Chemical_Compound
25569,29321,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25616,29321,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25619,29321,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
3613,29322,AKT inhibitor|pyruvate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5297,29322,AKT inhibitor|pyruvate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,29323,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7640,29326,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,29326,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,29326,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,29326,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,29326,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,29326,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7079,29327,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25826,29327,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
27204,29328,H+/K+-ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
29073,29329,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29330,29329,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29331,29329,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3947,29329,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3004,29332,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11307,29332,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25529,29332,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7103,29332,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6354,29334,GABA receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
3070,29334,GABA receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26190,29334,GABA receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7731,29334,GABA receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6354,29335,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
3070,29335,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26190,29335,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7731,29335,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25567,29335,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26163,29335,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8546,29343,TP53 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8546,29344,TP53 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13141,29345,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8546,29345,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,29346,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,29346,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,29346,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,29346,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,29347,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,29347,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,29347,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,29348,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,29348,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,29348,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,29348,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,29348,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12460,29349,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14372,29349,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,29349,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2676,29352,Pim kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25522,29359,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
3148,29360,cytochrome P450 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7020,29367,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7633,29367,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6190,29367,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25525,29372,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25934,29372,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,29377,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8337,29378,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12418,29381,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25710,29382,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25585,29384,histamine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
9570,29387,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9941,29387,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5184,29387,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11646,29387,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10173,29390,PI4K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3595,29391,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,29391,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7715,29391,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5938,29391,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25987,29392,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9535,29393,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7351,29394,dipeptidyl peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,29395,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7640,29396,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4180,29399,stearoyl-CoA desaturase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9018,29400,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,29400,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5185,29401,receptor tyrosine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25604,29401,receptor tyrosine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9018,29402,serine/threonine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
28320,29403,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25542,29404,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,29405,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25519,29406,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,29407,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7079,29407,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25526,29407,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7020,29407,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7633,29407,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25542,29408,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
3188,29409,beta-catenin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15679,29409,beta-catenin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13139,29410,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26243,29412,ICAM1 expression inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8346,29413,immunostimulant,MoA,Preclinical,Gene,Chemical_Compound
11666,29413,immunostimulant,MoA,Preclinical,Gene,Chemical_Compound
25690,29413,immunostimulant,MoA,Preclinical,Gene,Chemical_Compound
27042,29416,sphingosine 1-phosphate receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25555,29419,acetylcholine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25837,29419,acetylcholine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
12907,29420,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13590,29420,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11200,29420,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26465,29421,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4171,29421,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10758,29422,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,29422,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26465,29422,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,29422,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,29422,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7392,29422,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,29422,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,29422,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,29422,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,29422,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,29422,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,29422,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10758,29423,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,29423,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4774,29423,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,29423,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11393,29424,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10758,29425,Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5820,29425,Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,29426,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15284,29426,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,29427,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25631,29428,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
15539,29433,calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25847,29438,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25849,29438,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14233,29441,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25518,29442,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14109,29446,glucocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25581,29450,GABA receptor negative allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
8041,29451,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25697,29451,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
9810,29451,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25698,29451,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4277,29452,nitric oxide donor,MoA,Launched,Gene,Chemical_Compound
6859,29454,TP53 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,29456,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
15076,29456,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25749,29457,sodium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
26412,29458,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26062,29469,topical anesthetic,MoA,Phase 2,Gene,Chemical_Compound
26338,29472,CCK receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
26340,29472,CCK receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25775,29486,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25889,29486,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25631,29487,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,29487,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25527,29487,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27032,29487,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8584,29492,heme oxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25585,29494,histamine receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
26288,29496,JAK inhibitor|SYK inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
27136,29497,SYK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27762,29497,SYK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26288,29497,SYK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
29498,29499,polycomb repressive complex inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25525,29501,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25526,29501,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7079,29502,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
29503,29504,NTPDase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,29505,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25697,29505,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25698,29505,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8041,29506,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,29506,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25698,29506,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8041,29507,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25697,29507,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,29507,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25698,29507,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8041,29508,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25697,29508,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,29508,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25698,29508,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26016,29509,glucose dependent insulinotropic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25847,29510,cannabinoid receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7292,29512,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
5130,29513,hypoxia inducible factor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25636,29514,cyclooxygenase inhibitor|PPAR receptor agonist,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4229,29515,HSP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25567,29516,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25826,29516,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10922,29517,smoothened receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25998,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26000,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8606,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3621,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8763,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3556,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14918,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9372,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4103,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9528,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3239,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9058,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9292,29518,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,29519,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29519,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5659,29519,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,29519,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14107,29519,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26374,29519,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,29519,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29520,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5659,29520,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,29520,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,29520,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5719,29520,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10260,29520,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8955,29521,tissue transglutaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26048,29521,tissue transglutaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15745,29521,tissue transglutaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25847,29522,thioredoxin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9075,29522,thioredoxin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13493,29524,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,29524,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29525,29524,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3775,29524,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28833,29524,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15946,29526,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12989,29526,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9570,29531,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7333,29532,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3844,29532,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15642,29534,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,29535,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5659,29535,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11699,29535,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15642,29536,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13063,29537,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12418,29538,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12939,29538,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25766,29541,leukotriene synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25976,29541,leukotriene synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25518,29545,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25519,29545,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25517,29550,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25518,29550,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25519,29550,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25520,29550,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25522,29550,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25525,29550,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7079,29550,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25526,29550,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25522,29551,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,29551,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25525,29551,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29551,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,29551,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25567,29551,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26163,29551,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25933,29551,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25771,29551,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5185,29552,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25603,29552,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25604,29552,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7392,29552,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,29552,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4171,29552,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4449,29553,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
2774,29553,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25933,29554,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
2774,29555,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4293,29556,AXL kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12202,29557,diacylglycerol kinase inhibitor|protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25525,29558,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13139,29560,GABA receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25518,29562,dopamine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25519,29562,dopamine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25522,29562,dopamine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25929,29563,dopamine-norepinephrine reuptake inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9018,29564,RAF inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2742,29571,aldose reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25512,29575,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25514,29575,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25515,29575,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25523,29575,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25524,29575,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25824,29575,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29575,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15365,29576,ERK1 and ERK2 phosphorylation inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5719,29576,ERK1 and ERK2 phosphorylation inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12161,29577,Ral GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12295,29577,Ral GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10758,29579,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5820,29579,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
27136,29579,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25603,29579,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26465,29579,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13780,29579,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15786,29579,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25544,29581,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14717,29582,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15643,29582,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25561,29585,vasopressin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26123,29585,vasopressin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26124,29585,vasopressin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26125,29585,vasopressin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25623,29586,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13139,29587,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
10339,29588,transferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25518,29589,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25519,29589,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25520,29589,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25525,29589,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
14233,29589,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
28116,29591,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26200,29591,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
2774,29592,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14448,29593,toll-like receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27292,29595,toll-like receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
28094,29595,toll-like receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
9570,29596,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5184,29596,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15499,29596,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11646,29596,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11536,29598,cytochrome P450 inhibitor|SIRT activator,MoA,Launched,Gene,Chemical_Compound
15168,29598,cytochrome P450 inhibitor|SIRT activator,MoA,Launched,Gene,Chemical_Compound
7829,29598,cytochrome P450 inhibitor|SIRT activator,MoA,Launched,Gene,Chemical_Compound
25636,29598,cytochrome P450 inhibitor|SIRT activator,MoA,Launched,Gene,Chemical_Compound
4229,29599,HSP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25766,29606,leukotriene receptor antagonist|lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10012,29608,MRP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,29609,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29610,29609,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,29609,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8227,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14263,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5659,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6044,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3305,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5178,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11699,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25603,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8086,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11600,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8949,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3775,29611,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5184,29612,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14831,29613,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11040,29613,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5212,29614,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25730,29614,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9570,29615,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5184,29615,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8514,29616,gamma secretase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9986,29617,MDM inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13076,29618,triacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5539,29618,triacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4909,29620,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7320,29629,prostanoid receptor agonist,MoA,Launched,Gene,Chemical_Compound
14636,29633,cell cycle inhibitor|PLK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14233,29638,sigma receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26380,29639,calcitonin antagonist,MoA,Launched,Gene,Chemical_Compound
25847,29641,cannabinoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25853,29641,cannabinoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25569,29644,benzodiazepine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
9986,29647,MDM inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25544,29648,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13991,29648,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25546,29648,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25522,29648,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25523,29648,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25524,29648,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25525,29648,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
7079,29648,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25526,29648,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25527,29648,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25933,29648,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25934,29648,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25555,29650,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25837,29650,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26633,29650,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12642,29654,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10506,29654,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2722,29654,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6322,29654,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7178,29654,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9446,29654,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,29654,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9902,29654,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9885,29655,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6139,29656,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
6139,29657,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
4203,29658,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7324,29659,NGF binding inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28480,29659,NGF binding inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25520,29660,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9852,29661,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25569,29662,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25611,29662,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25612,29662,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25571,29662,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25613,29662,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25614,29662,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25616,29662,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25619,29662,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25569,29663,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25611,29663,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25612,29663,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25613,29663,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
12418,29664,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3004,29664,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11307,29664,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25529,29664,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7103,29664,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4203,29665,glutamate receptor antagonist|monamine transporter modulator,MoA,Preclinical,Gene,Chemical_Compound
27789,29666,glucokinase activator,MoA,Preclinical,Gene,Chemical_Compound
25536,29667,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15298,29668,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9869,29669,oxidosqualene cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,29670,MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9018,29671,MEK inhibitor|RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14717,29671,MEK inhibitor|RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15643,29671,MEK inhibitor|RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5450,29671,MEK inhibitor|RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25525,29672,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29672,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,29672,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
29673,29674,kynurenine 3-monooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26967,29675,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
7625,29676,beta amyloid protein neurotoxicity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25522,29677,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
12907,29678,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6626,29680,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25636,29680,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
8227,29685,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11699,29685,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25820,29686,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
10141,29686,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26763,29686,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
9069,29686,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
13264,29687,GABA transaminase inhibitor,MoA,Launched,Gene,Chemical_Compound
26053,29687,GABA transaminase inhibitor,MoA,Launched,Gene,Chemical_Compound
10693,29688,ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27042,29694,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25988,29695,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
13973,29696,glucose 6-phosphate dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25544,29697,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25546,29697,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,29698,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29698,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,29698,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26427,29699,CCR antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,29700,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7079,29700,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25526,29700,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25544,29701,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25546,29701,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25826,29702,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25826,29703,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4266,29704,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26427,29704,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25567,29705,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25826,29706,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25826,29707,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25512,29708,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11871,29709,nitric oxide production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8680,29710,hedgehog pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25522,29711,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25523,29711,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25524,29711,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25525,29711,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
7079,29711,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25526,29711,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25527,29711,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25933,29711,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
12016,29712,cytochrome P450 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25775,29713,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7292,29714,androgen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
15946,29715,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13754,29716,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9999,29716,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26053,29717,tyrosinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25636,29720,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3105,29723,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11600,29723,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27292,29724,toll-like receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26243,29725,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29726,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25636,29726,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8227,29727,CDK inhibitor|DNA synthesis inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
14831,29727,CDK inhibitor|DNA synthesis inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25544,29728,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13991,29728,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25546,29728,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25512,29728,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25514,29728,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25515,29728,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8227,29729,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5659,29729,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26288,29730,SYK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4171,29731,SYK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26288,29731,SYK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15298,29732,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8227,29732,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5659,29732,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5178,29732,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26109,29733,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4909,29735,nitric oxide stimulant,MoA,Phase 1,Gene,Chemical_Compound
26823,29736,CAR antagonist,MoA,Preclinical,Gene,Chemical_Compound
13754,29737,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25522,29738,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25856,29739,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10748,29740,DNA polymerase inhibitor,MoA,Launched,Gene,Chemical_Compound
7555,29740,DNA polymerase inhibitor,MoA,Launched,Gene,Chemical_Compound
25647,29740,DNA polymerase inhibitor,MoA,Launched,Gene,Chemical_Compound
26653,29740,DNA polymerase inhibitor,MoA,Launched,Gene,Chemical_Compound
13139,29741,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25531,29741,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10388,29741,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2657,29741,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26252,29741,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9069,29744,PKC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13139,29745,benzodiazepine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10922,29746,smoothened receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7510,29746,smoothened receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7625,29748,beta amyloid protein neurotoxicity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10608,29749,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9267,29751,eukaryotic translation initiation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25573,29752,EGFR inhibitor|metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25722,29753,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25843,29753,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25844,29753,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
4968,29754,eukaryotic translation initiation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12018,29755,apoptosis stimulant,MoA,Phase 1,Gene,Chemical_Compound
29756,29757,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10922,29757,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29756,29758,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10922,29758,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7640,29761,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25817,29761,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10758,29762,SRC inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26411,29762,SRC inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
15786,29762,SRC inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
6491,29762,SRC inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
11061,29763,glycine transporter inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26150,29766,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14372,29767,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9986,29768,MDM inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13626,29769,rho associated kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,29771,c-Met inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7079,29773,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,29773,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11481,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25766,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25879,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,29774,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25826,29775,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11481,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25766,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26819,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25779,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8817,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13493,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25879,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3775,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5450,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4774,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25969,29776,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25612,29777,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25613,29777,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25614,29777,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25525,29778,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29778,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,29778,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,29779,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25523,29779,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25524,29779,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,29779,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29779,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,29779,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9645,29780,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29780,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6999,29780,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,29780,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,29781,CHK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29782,29783,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,29784,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29784,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,29784,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29782,29785,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
26200,29786,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25525,29787,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29787,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,29787,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7640,29788,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,29788,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6809,29788,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,29788,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25817,29788,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25879,29789,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29789,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25636,29789,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13453,29790,p38 MAPK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4449,29790,p38 MAPK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25525,29791,serotonin receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
7079,29791,serotonin receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25526,29791,serotonin receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25933,29791,serotonin receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25933,29792,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26380,29793,calcitonin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25934,29794,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25933,29795,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
29796,29797,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25680,29798,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25682,29798,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6190,29799,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
25933,29800,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25680,29801,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25682,29801,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6999,29802,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,29802,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29802,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15553,29803,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2774,29803,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6190,29804,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
2774,29805,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2774,29806,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9018,29807,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26265,29808,nociceptin/orphanin FQ receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25605,29809,urotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12477,29810,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
6567,29810,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
15105,29810,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
29811,29810,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
6190,29812,TRPV antagonist,MoA,Phase 2,Gene,Chemical_Compound
25605,29813,urotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25933,29814,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
15188,29815,kinesin-like spindle protein inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11481,29816,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12367,29816,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,29816,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10642,29816,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29816,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26367,29817,G protein-coupled receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
13626,29818,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9902,29818,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9570,29819,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26304,29819,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9941,29819,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5184,29819,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11348,29819,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11002,29819,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15499,29819,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3799,29819,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14636,29820,PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9570,29821,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5184,29821,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,29822,protein kinase activator,MoA,Preclinical,Gene,Chemical_Compound
29823,29824,dihydroorotate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25761,29825,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25636,29826,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25761,29827,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7829,29828,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,29829,protein tyrosine kinase activator,MoA,Preclinical,Gene,Chemical_Compound
25563,29830,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25564,29830,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25517,29830,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25518,29830,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
26265,29831,nociceptin/orphanin FQ receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25517,29832,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25521,29832,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,29832,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26048,29832,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29833,29832,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27204,29834,ATPase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12683,29835,MTH1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,29836,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25697,29836,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,29836,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25698,29836,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8227,29837,CHK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7517,29837,CHK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15816,29838,antioxidant,MoA,Preclinical,Gene,Chemical_Compound
25563,29842,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25564,29842,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25565,29842,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25566,29842,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9570,29843,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9941,29843,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5184,29843,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11348,29843,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11002,29843,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15499,29843,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26306,29843,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11646,29843,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3799,29843,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29844,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2774,29845,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26029,29846,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26030,29846,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3521,29846,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25722,29847,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12473,29848,tachykinin antagonist,MoA,Phase 1,Gene,Chemical_Compound
25525,29849,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29849,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25526,29849,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8041,29850,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25567,29851,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26163,29851,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,29852,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25523,29852,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25623,29853,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25623,29854,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25569,29856,GABA receptor antagonist|TP53 activator,MoA,Preclinical,Gene,Chemical_Compound
25806,29857,progesterone receptor agonist,MoA,Launched,Gene,Chemical_Compound
11142,29860,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4203,29860,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14160,29860,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14968,29860,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14717,29862,MEK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8514,29863,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4449,29864,cytokine production inhibitor|p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5212,29865,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26149,29865,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25683,29865,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25604,29865,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7392,29865,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,29865,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4171,29865,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7625,29866,beta amyloid inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13006,29867,intermediate conductance potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
6126,29868,vitamin D receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
26332,29869,D-amino acid oxidase Inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9986,29871,MDM inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25544,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
13991,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25546,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25518,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25519,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25520,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
13040,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25522,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25523,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25524,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25824,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25825,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25525,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25526,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25933,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25926,29873,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
26172,29875,prostaglandin inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27042,29878,lysophospholipid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
29879,29880,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27048,29880,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12752,29881,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9531,29881,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5241,29882,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14831,29883,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8047,29883,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11040,29883,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25603,29884,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2676,29884,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26168,29884,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3068,29884,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13139,29885,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25531,29885,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10745,29886,hepatocyte growth factor receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
29887,29888,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6921,29889,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27055,29890,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25626,29891,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27201,29892,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25626,29892,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29893,29894,steroidogenic factor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12418,29895,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11964,29901,DNA methyltransferase inhibitor|RNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25942,29902,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25549,29902,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25792,29902,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25794,29902,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25795,29902,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25633,29902,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25797,29902,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25544,29904,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13991,29904,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25546,29904,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14923,29906,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10315,29907,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14923,29907,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7559,29908,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2774,29908,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5173,29910,endothelin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
6150,29910,endothelin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
13355,29912,MDM inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14233,29913,sigma receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
13006,29914,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
4449,29915,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25516,29916,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25517,29916,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25521,29916,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25517,29917,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25517,29918,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25521,29918,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25517,29919,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25521,29919,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25766,29920,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29920,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26787,29921,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8064,29922,histamine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25779,29923,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
8834,29923,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9917,29923,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
28243,29923,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9770,29923,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26763,29923,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
6706,29923,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
14020,29924,sphingosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,29925,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25847,29926,cannabinoid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25518,29926,cannabinoid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25522,29926,cannabinoid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8041,29927,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25697,29927,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9810,29927,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25698,29927,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
4198,29928,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26205,29928,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8344,29928,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13208,29929,sigma receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29930,29931,autophagy inducer,MoA,Preclinical,Gene,Chemical_Compound
2676,29932,Pim kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29879,29933,transient receptor potential channel agonist,MoA,Preclinical,Gene,Chemical_Compound
4909,29935,nitric oxide donor,MoA,Phase 2,Gene,Chemical_Compound
25544,29936,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13991,29936,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25546,29936,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25512,29936,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25514,29936,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25515,29936,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15539,29936,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25942,29936,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11393,29939,selective estrogen receptor modulator (SERM),MoA,Preclinical,Gene,Chemical_Compound
13343,29940,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,29940,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25887,29940,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4229,29941,HSP inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
4111,29941,HSP inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7584,29942,thyroid hormone receptor agonist,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9625,29942,thyroid hormone receptor agonist,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7382,29943,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27063,29943,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27064,29943,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9570,29943,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9941,29943,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5184,29943,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11646,29943,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3105,29950,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2742,29956,aldose reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25993,29957,sodium/glucose cotransporter inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26591,29957,sodium/glucose cotransporter inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7247,29959,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26723,29959,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15425,29959,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25736,29959,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12513,29959,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25737,29959,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10073,29960,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13922,29960,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9986,29961,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12989,29963,bacterial DNA gyrase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25647,29964,aspartate carbamoyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25648,29964,aspartate carbamoyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2944,29965,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6813,29965,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26048,29966,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
8235,29966,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
29968,29969,gene expression stimulant,MoA,Preclinical,Gene,Chemical_Compound
25843,29971,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25544,29974,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13991,29974,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25546,29974,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25512,29974,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25514,29974,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25515,29974,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,29974,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29974,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10315,29975,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5173,29976,endothelin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4171,29977,receptor tyrosine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11239,29978,bacterial cell wall synthesis inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4467,29979,adenylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15412,29980,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
29981,29980,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12473,29982,neurokinin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10141,29983,PPAR receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
29981,29984,retinoid receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
26815,29985,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26338,29986,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13493,29987,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,29987,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3775,29987,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13493,29988,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9902,29989,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25567,29990,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25631,29991,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25775,29991,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25889,29991,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25563,29992,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4588,29993,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,29993,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4774,29993,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3272,29994,serine arginine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10260,29994,serine arginine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10315,29995,SIRT activator,MoA,Preclinical,Gene,Chemical_Compound
10315,29996,SIRT activator,MoA,Phase 2,Gene,Chemical_Compound
25542,29997,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12125,29998,myeloid differentiation primary response inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26037,29999,interleukin synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8551,30000,STAT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6024,30001,aryl hydrocarbon receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6202,30002,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13063,30003,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13063,30004,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14676,30004,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25544,30006,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25563,30008,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25564,30008,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25565,30008,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25566,30008,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9280,30008,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26753,30008,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27732,30008,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6354,30008,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
3070,30008,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26190,30008,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7731,30008,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12473,30009,neurokinin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25568,30009,neurokinin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
29782,30009,neurokinin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
30016,30017,antioxidant,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
10895,30020,dihydrofolate reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11871,30028,anticancer agent|aryl hydrocarbon receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25647,30031,carbonic anhydrase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25518,30032,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
30034,30035,calcitonin agonist,MoA,Preclinical,Gene,Chemical_Compound
5212,30036,fibroblast growth factor mimetic,MoA,Preclinical,Gene,Chemical_Compound
7829,30038,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25636,30038,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13139,30041,GABA receptor inverse agonist,MoA,Phase 2,Gene,Chemical_Compound
25683,30042,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,30043,hepatocyte growth factor receptor inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,30044,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,30045,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,30046,PDGFR tyrosine kinase receptor inhibitor|tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,30046,PDGFR tyrosine kinase receptor inhibitor|tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,30047,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,30047,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5659,30047,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,30047,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9932,30048,alpha mannosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,30049,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8327,30050,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11784,30050,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28237,30050,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28238,30050,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28239,30050,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26843,30050,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25963,30051,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25961,30051,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15548,30051,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25965,30051,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27042,30053,sphingosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25963,30054,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
25961,30054,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
15548,30054,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
25965,30054,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
10141,30055,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7555,30056,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26653,30056,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10141,30057,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11214,30058,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15076,30059,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
13677,30059,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
9476,30059,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
11708,30059,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
26890,30059,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
14857,30059,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
10073,30060,AP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7284,30061,LIM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25697,30062,adenosine receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
10658,30063,casein kinase inhibitor|MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10045,30063,casein kinase inhibitor|MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30063,casein kinase inhibitor|MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25983,30064,growth hormone secretagogue receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
9570,30066,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12212,30073,phosphorylase inhibitor,MoA,Launched,Gene,Chemical_Compound
26571,30074,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25691,30075,CC chemokine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
13590,30076,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7392,30077,VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9018,30078,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30079,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14717,30080,MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25820,30081,insulin secretagogue,MoA,Phase 3,Gene,Chemical_Compound
8285,30082,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14636,30083,PLK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7351,30084,dipeptidyl peptidase inhibitor|fibroblast activation protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26154,30085,smoothened receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
27005,30085,smoothened receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10922,30085,smoothened receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25963,30086,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25961,30086,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
15548,30086,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25965,30086,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
28449,30087,cytochrome P450 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25991,30091,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25879,30091,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,30091,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3680,30091,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25969,30091,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25568,30092,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
29782,30092,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25892,30094,adrenergic inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25806,30099,progesterone receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
5185,30101,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25603,30101,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25604,30101,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3848,30101,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12302,30101,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4229,30102,HSP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
29083,30104,AP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25991,30105,anti-inflammatory agent|interleukin inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26890,30105,anti-inflammatory agent|interleukin inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25969,30105,anti-inflammatory agent|interleukin inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
9776,30106,prostaglandin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25565,30107,acetylcholine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25847,30108,cannabinoid receptor inverse agonist,MoA,Phase 3,Gene,Chemical_Compound
26109,30109,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25702,30110,P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15946,30111,topoisomerase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,30112,PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11348,30114,angiogenesis inhibitor|S100A9 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
30115,30116,G protein-coupled receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
26774,30116,G protein-coupled receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
29461,30116,G protein-coupled receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
13395,30117,opioid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11100,30119,histone lysine methyltransferase inhibitor,MoA,Launched,Gene,Chemical_Compound
3815,30120,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26843,30120,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6594,30120,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28330,30120,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28331,30120,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,30121,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4997,30122,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14472,30122,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12416,30123,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8621,30123,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7816,30123,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12722,30123,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27861,30123,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15241,30123,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11184,30123,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7625,30124,gamma secretase modulator,MoA,Preclinical,Gene,Chemical_Compound
25856,30125,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30126,30127,formyl peptide receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25512,30128,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25514,30128,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25515,30128,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25697,30129,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26367,30130,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5432,30131,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9570,30132,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9941,30132,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5184,30132,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11646,30132,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15694,30133,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15105,30133,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25988,30134,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
25988,30135,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
30136,30137,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28833,30138,monopolar spindle 1 kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25797,30139,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
28618,30140,neurotensin agonist,MoA,Preclinical,Gene,Chemical_Compound
28211,30141,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25561,30142,oxytocin receptor agonist|vasopressin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
30143,30142,oxytocin receptor agonist|vasopressin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26411,30144,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8328,30145,DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13005,30145,DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26377,30146,PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13234,30147,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5130,30148,hypoxia inducible factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27042,30149,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11142,30150,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27201,30151,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
15499,30152,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25682,30153,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2676,30154,Pim kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,30155,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,30156,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12477,30157,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15105,30157,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26522,30158,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25603,30159,FLT3 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10608,30160,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
6908,30161,beta-secretase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25555,30162,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8041,30164,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26582,30165,calcium-sensing receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25926,30166,histamine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25525,30167,serotonin receptor partial agonist,MoA,Withdrawn,Gene,Chemical_Compound
7079,30167,serotonin receptor partial agonist,MoA,Withdrawn,Gene,Chemical_Compound
25526,30167,serotonin receptor partial agonist,MoA,Withdrawn,Gene,Chemical_Compound
25826,30167,serotonin receptor partial agonist,MoA,Withdrawn,Gene,Chemical_Compound
26427,30168,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25683,30170,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3725,30171,calcitonin antagonist,MoA,Phase 3,Gene,Chemical_Compound
15447,30171,calcitonin antagonist,MoA,Phase 3,Gene,Chemical_Compound
25563,30172,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
27440,30180,ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26048,30182,cyclooxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7829,30182,cyclooxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10315,30185,SIRT inhibitor|TP53 activator,MoA,Preclinical,Gene,Chemical_Compound
10315,30186,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14923,30186,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4184,30186,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14456,30189,pyruvate kinase isozyme activator,MoA,Preclinical,Gene,Chemical_Compound
30190,30191,lipoxygenase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15298,30191,lipoxygenase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13040,30195,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
5402,30195,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25926,30195,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25607,30199,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26884,30200,prostanoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
8337,30201,insulin sensitizer|PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
10141,30201,insulin sensitizer|PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7103,30202,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7992,30205,superoxide dismutase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
16048,30205,superoxide dismutase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
30207,30208,cytidine deaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25929,30210,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25623,30211,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11142,30211,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4203,30211,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14160,30211,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14968,30211,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7020,30212,monoamine oxidase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27817,30213,prostaglandin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3181,30214,CLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4445,30214,CLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8328,30214,CLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13005,30214,CLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,30215,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
8227,30215,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5178,30215,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11699,30215,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25603,30215,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11600,30215,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25683,30216,SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,30216,SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4588,30217,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5212,30217,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26149,30217,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26150,30217,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25683,30217,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15786,30217,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11600,30218,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,30218,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,30219,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,30219,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,30220,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6809,30220,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12097,30220,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25817,30220,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12683,30221,MTH1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,30223,phosphodiesterase inhibitor,MoA,Launched,Gene,Chemical_Compound
25697,30223,phosphodiesterase inhibitor,MoA,Launched,Gene,Chemical_Compound
11307,30223,phosphodiesterase inhibitor,MoA,Launched,Gene,Chemical_Compound
30224,30225,GLCNAC phosphotransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25585,30234,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25932,30234,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25517,30236,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25518,30236,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25519,30236,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25520,30236,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25521,30236,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
13040,30236,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25522,30236,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25525,30236,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25526,30236,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25933,30236,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25934,30236,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
15883,30237,membrane metalloendopeptidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5178,30243,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5178,30244,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5178,30245,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,30253,AKT inhibitor|TRAIL modulator,MoA,Phase 2,Gene,Chemical_Compound
15365,30253,AKT inhibitor|TRAIL modulator,MoA,Phase 2,Gene,Chemical_Compound
8086,30254,glycogen synthase kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27026,30255,cytochrome P450 inhibitor|sodium/potassium/chloride transporter inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
5054,30255,cytochrome P450 inhibitor|sodium/potassium/chloride transporter inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25683,30256,TIE tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30256,TIE tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25650,30257,ATP-sensitive potassium channel agonist,MoA,Phase 1,Gene,Chemical_Compound
25654,30257,ATP-sensitive potassium channel agonist,MoA,Phase 1,Gene,Chemical_Compound
7449,30259,cholesterol inhibitor|lipase clearing factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25584,30261,histamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25647,30263,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3325,30264,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9265,30264,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4768,30265,plasminogen activator inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25631,30266,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25775,30266,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25889,30266,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25633,30267,sodium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
10745,30270,tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14905,30273,cyclophilin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11461,30274,methionine aminopeptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25631,30280,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25775,30280,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25889,30280,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
7628,30284,catechol O methyltransferase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13780,30285,SRC activator,MoA,Phase 2,Gene,Chemical_Compound
15786,30285,SRC activator,MoA,Phase 2,Gene,Chemical_Compound
25512,30287,adrenergic receptor antagonist,MoA,Launched,Gene,Chemical_Compound
3984,30290,aldose reductase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
2742,30290,aldose reductase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
30291,30290,aldose reductase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
26815,30294,leukotriene receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25979,30299,cholesteryl ester transfer protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14769,30300,DNA polymerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10014,30300,DNA polymerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7640,30302,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,30303,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9311,30304,peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14765,30304,peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15620,30304,peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6202,30305,serine/threonine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25697,30306,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13343,30307,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8285,30307,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25887,30307,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26411,30307,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25569,30308,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25611,30308,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25612,30308,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25613,30308,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
4293,30309,AXL kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
8456,30310,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25569,30311,GABA receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
13006,30312,potassium channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
13006,30313,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
7625,30315,beta amyloid protein neurotoxicity inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26265,30320,nociceptin/orphanin FQ receptor antagonist|opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,30323,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11214,30328,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15168,30329,DNA replication inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7850,30335,ribonucleotide reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26857,30335,ribonucleotide reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9570,30337,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26304,30337,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9941,30337,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5184,30337,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11348,30337,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11002,30337,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15499,30337,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26306,30337,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11646,30337,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3799,30337,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11481,30338,AKT inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
3613,30338,AKT inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12367,30338,AKT inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10895,30353,dihydrofolate reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25523,30357,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25524,30357,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
3844,30358,RNA polymerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
29083,30360,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6026,30360,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25969,30360,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27025,30361,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
10141,30361,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
9069,30361,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25567,30363,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26163,30363,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7829,30364,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
25636,30364,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
12989,30368,bacterial DNA gyrase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25844,30369,opioid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
27440,30370,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6481,30372,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
14201,30372,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
6665,30372,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
11536,30373,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15499,30374,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,30377,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25820,30378,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25756,30379,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5075,30381,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
16033,30381,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13264,30381,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,30382,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10073,30382,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5216,30382,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12316,30383,sphingosine 1-phosphate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25603,30384,FLT3 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30385,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30385,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30386,EGFR inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30387,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,30388,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30389,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,30390,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,30390,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25937,30390,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30391,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15643,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15781,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25879,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5450,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,30392,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7628,30393,catechol O methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10748,30394,carbonic anhydrase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7555,30394,carbonic anhydrase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25647,30394,carbonic anhydrase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26653,30394,carbonic anhydrase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25843,30395,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25843,30396,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25983,30397,growth hormone releasing factor agonist,MoA,Phase 1,Gene,Chemical_Compound
25519,30398,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7351,30399,dipeptidyl peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3360,30399,dipeptidyl peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25553,30400,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25555,30400,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25837,30400,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8327,30402,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8327,30403,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8327,30404,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28239,30404,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8344,30405,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9570,30406,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9941,30406,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5184,30406,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11646,30406,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25518,30408,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25519,30408,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25520,30408,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,30408,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26030,30409,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3464,30409,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3521,30409,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11446,30409,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25573,30409,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11792,30410,procollagen C-endopeptidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7323,30411,monocarboxylate transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2788,30414,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30414,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30415,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30416,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2788,30417,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30417,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2788,30418,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30418,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30419,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2788,30420,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30420,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8956,30421,L3MBTL antagonist,MoA,Preclinical,Gene,Chemical_Compound
11100,30422,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25603,30423,FLT3 inhibitor|MER tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26448,30423,FLT3 inhibitor|MER tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26448,30424,MER tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5241,30425,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6722,30426,phosphatidyl-inositol activator,MoA,Preclinical,Gene,Chemical_Compound
15068,30427,L3MBTL antagonist,MoA,Preclinical,Gene,Chemical_Compound
15068,30428,MBT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9999,30429,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,30430,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3613,30430,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12367,30430,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25856,30433,FAAH inhibitor,MoA,Phase 1,Gene,Chemical_Compound
30434,30433,FAAH inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10608,30433,FAAH inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14897,30438,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12092,30438,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25711,30439,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
25713,30439,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
25714,30439,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
28842,30439,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
5392,30439,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
30440,30441,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3594,30441,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25603,30441,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4204,30441,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7973,30441,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6110,30441,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4029,30441,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27762,30441,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10260,30441,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7333,30443,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26775,30443,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4909,30443,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25690,30443,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4909,30444,MAP kinase activator,MoA,Preclinical,Gene,Chemical_Compound
7555,30445,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25636,30445,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25702,30454,P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25929,30466,dopamine reuptake inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27223,30469,secretory phospholipase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12907,30471,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26149,30471,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26150,30471,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25683,30471,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,30471,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2744,30472,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4497,30472,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5876,30472,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15816,30473,ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12946,30474,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15816,30474,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7640,30474,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25817,30474,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25976,30477,leukotriene synthesis inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13754,30478,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9999,30478,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26728,30479,neuropeptide receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13141,30483,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4229,30484,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30486,30487,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
28413,30488,urate transporter inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7762,30490,tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
30491,30492,acetylcholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14448,30494,tumor necrosis factor receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25691,30495,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25563,30504,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25564,30504,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25565,30504,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25566,30504,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
8041,30509,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25697,30509,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9810,30509,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25698,30509,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25766,30511,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
12202,30511,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
26890,30511,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
9934,30511,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
6055,30511,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
7247,30511,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
26723,30511,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
6266,30511,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
30512,30511,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
30513,30511,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
8546,30514,antitumor agent|ubiquitin C-terminal hydrolase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8301,30514,antitumor agent|ubiquitin C-terminal hydrolase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14636,30516,PLK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25525,30517,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
7079,30517,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25526,30517,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25926,30517,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12989,30520,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7640,30524,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,30524,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25920,30525,beta amyloid antagonist,MoA,Phase 1,Gene,Chemical_Compound
8124,30525,beta amyloid antagonist,MoA,Phase 1,Gene,Chemical_Compound
25581,30526,cytochrome P450 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25800,30527,renin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25567,30528,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26163,30528,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25932,30529,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5446,30530,CC chemokine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8093,30531,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9280,30532,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26523,30533,potassium/chloride cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25626,30534,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25626,30535,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
27201,30536,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
27201,30537,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
3540,30538,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27201,30539,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26832,30540,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25566,30541,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25566,30542,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25626,30543,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25626,30544,glutamate receptor potentiator,MoA,Preclinical,Gene,Chemical_Compound
25652,30545,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
15365,30546,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25991,30547,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6026,30547,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25879,30547,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15947,30547,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,30547,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25969,30547,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25879,30548,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15947,30548,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,30548,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4815,30549,caspase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7612,30550,anaphylatoxin chemotactic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,30552,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25526,30553,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26030,30554,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,30555,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26217,30555,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11200,30555,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25596,30555,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25575,30556,gonadotropin releasing factor hormone receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25584,30556,gonadotropin releasing factor hormone receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25568,30556,gonadotropin releasing factor hormone receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25518,30557,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25525,30557,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,30557,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25933,30557,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25934,30557,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26843,30558,glutamate inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12497,30559,secreted frizzled related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26739,30560,FXR agonist,MoA,Phase 1,Gene,Chemical_Compound
7640,30561,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25526,30562,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25544,30563,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13991,30563,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25546,30563,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25512,30563,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25514,30563,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25515,30563,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,30563,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12594,30564,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,30565,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,30565,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30566,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3105,30566,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11600,30566,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,30566,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,30567,tankyrase inhibitor|WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7552,30568,aldehyde dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6161,30569,bradykinin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5205,30570,actin related protein inhibitor|neural Wiskott-Aldrich syndrome protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4919,30571,porcupine inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30572,30573,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12460,30573,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,30573,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,30573,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25817,30573,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5177,30573,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14636,30573,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,30573,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8551,30574,STAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11600,30575,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3127,30575,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8301,30575,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11055,30575,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30577,30578,carboxylesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9915,30579,monoacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,30580,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,30581,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,30582,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30583,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30584,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,30584,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7533,30585,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,30585,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30586,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25865,30587,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,30588,serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25631,30589,adrenergic receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25563,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25564,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25565,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25566,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
9280,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25522,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25523,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25524,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25824,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25825,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25525,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7079,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25526,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25933,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25934,30590,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7800,30591,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,30591,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9535,30592,benzodiazepine receptor ligand,MoA,Phase 2,Gene,Chemical_Compound
5999,30593,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14000,30593,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15528,30593,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28216,30593,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27109,30594,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25936,30594,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
2757,30594,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26345,30594,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
5524,30594,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
3105,30596,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11600,30596,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5775,30596,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,30597,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12097,30597,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25817,30597,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11627,30598,Abl kinase inhibitor|insulin growth factor receptor inhibitor|SRC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15786,30598,Abl kinase inhibitor|insulin growth factor receptor inhibitor|SRC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7640,30599,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30600,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6383,30600,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13590,30600,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26150,30600,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25683,30600,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15491,30601,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8849,30602,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15491,30602,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26151,30602,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30603,30602,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9052,30606,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11393,30607,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25596,30607,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11455,30608,potassium channel activator,MoA,Phase 1,Gene,Chemical_Compound
11455,30609,potassium channel activator,MoA,Phase 1,Gene,Chemical_Compound
12916,30610,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14999,30610,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5770,30610,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25736,30610,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,30610,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9902,30610,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7432,30611,prolyl endopeptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29823,30612,interleukin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,30613,rho associated kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9902,30613,rho associated kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14710,30614,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
26282,30614,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
26284,30614,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
7902,30614,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
25983,30615,ghrelin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
30616,30617,apoptosis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3421,30617,apoptosis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26340,30618,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
30190,30619,survivin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26967,30620,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26967,30621,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25911,30622,aromatase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28243,30623,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26763,30623,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10825,30623,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
8363,30624,ACAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
30625,30626,IL5 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30627,30626,IL5 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3004,30628,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10994,30629,piezo channel activator,MoA,Preclinical,Gene,Chemical_Compound
10043,30631,phosphofructokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4791,30631,phosphofructokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7710,30632,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25567,30633,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26163,30633,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25826,30633,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25527,30633,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8517,30635,calmodulin antagonist,MoA,Phase 3,Gene,Chemical_Compound
25584,30636,histamine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25565,30637,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26522,30639,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12646,30639,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7103,30639,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11214,30639,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26578,30639,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7103,30640,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28183,30641,HCN channel blocker,MoA,Phase 3,Gene,Chemical_Compound
30642,30641,HCN channel blocker,MoA,Phase 3,Gene,Chemical_Compound
28185,30641,HCN channel blocker,MoA,Phase 3,Gene,Chemical_Compound
28186,30641,HCN channel blocker,MoA,Phase 3,Gene,Chemical_Compound
2512,30643,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25889,30644,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25889,30645,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
5948,30646,angiotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28183,30647,HCN channel blocker,MoA,Phase 2,Gene,Chemical_Compound
30642,30647,HCN channel blocker,MoA,Phase 2,Gene,Chemical_Compound
28185,30647,HCN channel blocker,MoA,Phase 2,Gene,Chemical_Compound
28186,30647,HCN channel blocker,MoA,Phase 2,Gene,Chemical_Compound
30207,30648,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14831,30648,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5173,30649,endothelin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
7020,30653,selective serotonin reuptake inhibitor (SSRI),MoA,Withdrawn,Gene,Chemical_Compound
7633,30653,selective serotonin reuptake inhibitor (SSRI),MoA,Withdrawn,Gene,Chemical_Compound
25771,30653,selective serotonin reuptake inhibitor (SSRI),MoA,Withdrawn,Gene,Chemical_Compound
11393,30655,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25596,30655,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25562,30656,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25569,30657,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25611,30657,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25612,30657,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25613,30657,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25616,30657,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25619,30657,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25569,30658,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25611,30658,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25612,30658,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25613,30658,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
13924,30659,AMPK activator,MoA,Preclinical,Gene,Chemical_Compound
7535,30659,AMPK activator,MoA,Preclinical,Gene,Chemical_Compound
13398,30659,AMPK activator,MoA,Preclinical,Gene,Chemical_Compound
8041,30660,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25697,30660,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,30660,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25698,30660,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12907,30661,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26149,30661,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26150,30661,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,30661,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25683,30662,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9018,30663,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,30663,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30663,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5450,30663,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3105,30664,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,30664,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,30665,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,30665,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26172,30669,prostaglandin synthesis inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
11988,30670,sodium/hydrogen exchanger inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25702,30676,P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
30677,30676,P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6809,30680,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12097,30680,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25817,30680,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7440,30682,N-type calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
11600,30683,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3823,30684,benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MoA,Phase 1,Gene,Chemical_Compound
27223,30684,benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MoA,Phase 1,Gene,Chemical_Compound
25920,30684,benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MoA,Phase 1,Gene,Chemical_Compound
8870,30685,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,30685,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,30685,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,30685,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9932,30686,alpha mannosidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26388,30687,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27146,30687,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27148,30687,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
13006,30687,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
14586,30688,sphingosine 1-phosphate receptor substrate,MoA,Preclinical,Gene,Chemical_Compound
27203,30688,sphingosine 1-phosphate receptor substrate,MoA,Preclinical,Gene,Chemical_Compound
15786,30689,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25567,30691,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26163,30691,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
2676,30692,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15946,30693,topoisomerase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10555,30694,PKC activator,MoA,Phase 2,Gene,Chemical_Compound
6139,30694,PKC activator,MoA,Phase 2,Gene,Chemical_Compound
26412,30695,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25913,30695,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26109,30695,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26922,30696,prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8041,30698,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
16033,30699,BCL-XL downregulator,MoA,Preclinical,Gene,Chemical_Compound
9075,30700,thioredoxin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7625,30701,ATP synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27274,30702,hemoglobin modulator,MoA,Phase 2,Gene,Chemical_Compound
28320,30703,glutamate carboxypeptidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25826,30704,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7555,30705,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25646,30705,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25647,30705,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26652,30705,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26653,30705,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9917,30706,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
28243,30706,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
9770,30706,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
26763,30706,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
7510,30706,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
25904,30706,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
26051,30706,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
9069,30706,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
30707,30706,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
6190,30706,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
30708,30706,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
25512,30709,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25514,30709,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25515,30709,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
7020,30709,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
7633,30709,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
8041,30710,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25697,30710,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,30710,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25698,30710,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8041,30711,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25697,30711,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,30711,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25518,30712,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25520,30712,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14676,30713,glycolysis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
30714,30713,glycolysis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
30715,30713,glycolysis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11730,30713,glycolysis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7292,30717,androgen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13139,30718,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25531,30718,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26412,30719,nitric oxide synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25913,30719,nitric oxide synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25754,30720,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25755,30720,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15168,30720,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7628,30721,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25911,30721,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26315,30721,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3148,30721,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7902,30721,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7762,30721,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25523,30722,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,30722,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25824,30722,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25825,30722,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25567,30722,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26163,30722,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25933,30722,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26016,30723,glucose dependent insulinotropic receptor ligand,MoA,Phase 1,Gene,Chemical_Compound
2925,30726,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25754,30727,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25755,30727,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25544,30728,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13040,30729,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13722,30730,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25518,30731,dopamine receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25626,30732,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7292,30733,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
7902,30733,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
29083,30733,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
30734,30733,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
26834,30735,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26834,30736,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15786,30737,SRC inhibitor|SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26288,30737,SRC inhibitor|SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26967,30738,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25563,30739,dopamine uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25892,30739,dopamine uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25929,30739,dopamine uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25771,30739,dopamine uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,30742,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25567,30743,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26412,30744,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25913,30744,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26109,30744,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3157,30745,hexokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25623,30746,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,30746,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,30746,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,30746,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26967,30747,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25626,30747,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15252,30748,adenosylhomocysteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11100,30749,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26967,30753,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2925,30754,GABA aminotransferase activator,MoA,Preclinical,Gene,Chemical_Compound
30734,30755,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25544,30756,adrenergic receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
4791,30757,phosphofructokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11536,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26411,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25879,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,30758,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25525,30759,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26967,30761,glutamate receptor agonist|glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26967,30762,glutamate receptor agonist|glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26396,30762,glutamate receptor agonist|glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12347,30763,urokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27063,30764,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25563,30765,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25564,30765,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25565,30765,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25566,30765,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9280,30765,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13754,30766,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14233,30767,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10043,30769,macrophage migration inhibiting factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25911,30770,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2833,30770,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27085,30770,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25735,30770,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4277,30770,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25932,30771,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6202,30772,IRE1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25754,30773,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25755,30773,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14233,30774,sigma receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25542,30775,nicotinic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6821,30776,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6821,30777,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7720,30777,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9570,30778,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8041,30779,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
3070,30780,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25623,30780,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,30780,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,30780,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,30780,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14968,30780,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9226,30783,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25522,30784,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25523,30784,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25524,30784,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25824,30784,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25825,30784,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25525,30784,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7079,30784,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25526,30784,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25527,30784,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25933,30784,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25934,30784,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14652,30786,thymidylate synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25565,30787,acetylcholine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25563,30790,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25564,30790,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25565,30790,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25566,30790,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25754,30791,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25755,30791,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6190,30792,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
25623,30793,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,30793,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,30793,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,30793,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25518,30794,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25519,30794,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25519,30795,dopamine receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
15298,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7517,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8332,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8086,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26411,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10696,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4583,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5297,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7247,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26723,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15425,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25736,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27437,30796,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6859,30797,acetylcholinesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26412,30798,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25913,30798,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26109,30798,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8196,30799,PKA activator,MoA,Preclinical,Gene,Chemical_Compound
25527,30800,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25934,30800,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25518,30801,dopamine receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25519,30801,dopamine receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25754,30802,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25755,30802,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15946,30803,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
